10-Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

TQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended November 30, 2013

or

£TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ..... to …..

Commission file number: 001-14669

HELEN OF TROY LIMITED

(Exact name of registrant as specified in its charter)

Bermuda	74-2692550
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
Clarenden House Church Street Hamilton, Bermuda
(Address of principal executive offices)
1 Helen of Troy Plaza
El Paso, Texas	79912
(Registrant’s United States Mailing Address)	(Zip Code)

(915) 225-8000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                                                                        Yes T      No £

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).            Yes T      No £

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer T	Accelerated filer £
Non-accelerated filer   £ (Do not check if a smaller reporting company)	Smaller reporting company  £

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes £      No T

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class	Outstanding at January 3, 2014
Common Shares, $0.10 par value, per share	32,064,062 shares

HELEN OF TROY LIMITED AND SUBSIDIARIES

INDEX – FORM 10-Q

			Page
PART I.	FINANCIAL INFORMATION
	Item 1.	Financial Statements
		Consolidated Condensed Balance Sheets (Unaudited) as of November 30, 2013 and February 28, 2013	3
		Consolidated Condensed Statements of Income (Unaudited) for the Three- and Nine-Months Ended November 30, 2013 and November 30, 2012	4
		Consolidated Condensed Statements of Comprehensive Income (Unaudited) for the Three- and Nine-Months Ended November 30, 2013 and November 30, 2012	5
		Consolidated Condensed Statements of Cash Flows (Unaudited) for the Nine Months Ended November 30, 2013 and November 30, 2012	6
		Notes to Consolidated Condensed Financial Statements (Unaudited)	7
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
	Item 3.	Quantitative and Qualitative Disclosures about Market Risk	37
	Item 4.	Controls and Procedures	41
PART II.	OTHER INFORMATION
	Item 1.	Legal Proceedings	42
	Item 1A.	Risk Factors	42
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	42
	Item 6.	Exhibits	43
	Signatures		44

- 2 -

PART I.   FINANCIAL INFORMATION

ITEM 1.   FINANCIAL STATEMENTS

HELEN OF TROY LIMITED AND SUBSIDIARIES

Consolidated Condensed Balance Sheets (Unaudited)

(in thousands, except shares and par value)

	November 30,			February 28,
	2013			2013
Assets
Assets, current:
Cash and cash equivalents	$	28,775		$	12,842
Receivables - principally trade, less allowances of $4,653 and $5,031	279,699			219,719
Inventory, net	289,890			280,872
Prepaid expenses and other current assets	10,321			8,442
Income taxes receivable	-			1,800
Deferred tax assets, net	25,314			21,530
Total assets, current	633,999			545,205
Property and equipment, net of accumulated depreciation of $74,576 and $74,775	130,577			101,716
Goodwill	453,241			453,241
Other intangible assets, net of accumulated amortization of $89,504 and $73,344	327,604			355,628
Deferred tax assets, net	2,780			2,401
Other assets, net of accumulated amortization of $6,214 and $5,403	10,819			15,813
Total assets	$	1,559,020		$	1,474,004
Liabilities and Stockholders’ Equity
Liabilities, current:
Revolving line of credit	$	4,900		$	82,000
Accounts payable, principally trade	93,322			72,263
Accrued expenses and other current liabilities	158,536			134,063
Income taxes payable	1,261			-
Deferred tax liabilities, net	243			339
Long-term debt, current maturities	96,900			20,000
Total liabilities, current	355,162			308,665
Long-term debt, excluding current maturities	113,609			155,000
Deferred tax liabilities, net	55,880			57,991
Other liabilities, non-current	24,547			25,742
Total liabilities	549,198			547,398
Commitments and contingencies
Stockholders’ equity:
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued	-			-
Common stock, $0.10 par. Authorized 50,000,000 shares; 32,053,272 and 31,868,416 shares issued and outstanding	3,205			3,187
Additional paid in capital	172,766			164,471
Accumulated other comprehensive loss	(1,726		)	(2,729		)
Retained earnings	835,577			761,677
Total stockholders’ equity	1,009,822			926,606
Total liabilities and stockholders’ equity	$	1,559,020		$	1,474,004

See accompanying notes to consolidated condensed financial statements.

- 3 -

HELEN OF TROY LIMITED AND SUBSIDIARIES

Consolidated Condensed Statements of Income (Unaudited)

(in thousands, except per share data)

	Three Months Ended November 30,						Nine Months Ended November 30,
	2013			2012				2013			2012
Sales revenue, net	$	380,730		$	374,599			$	1,004,633		$	962,221
Cost of goods sold	233,029			226,146				613,513			575,590
Gross profit	147,701			148,453				391,120			386,631
Selling, general and administrative expense	98,308			101,401				278,697			277,590
Asset impairment charges	-			-				12,049			-
Operating income	49,393			47,052				100,374			109,041
Nonoperating income (expense), net	13			(16		)		153			38
Interest expense	(2,513		)	(3,232		)		(7,647		)	(9,674		)
Income before income taxes	46,893			43,804				92,880			99,405
Income tax expense (benefit):
Current	10,911			11,705				24,780			26,093
Deferred	(1,542		)	(5,620		)		(7,133		)	(10,847		)
Net income	$	37,524		$	37,719			$	75,233		$	84,159
Earnings per share:
Basic	$	1.17		$	1.19			$	2.35		$	2.65
Diluted	$	1.16		$	1.18			$	2.33		$	2.64
Weighted average shares of common stock used in computing net earnings per share:
Basic	32,047			31,775				31,982			31,739
Diluted	32,482			31,970				32,311			31,885

See accompanying notes to consolidated condensed financial statements.

- 4 -

HELEN OF TROY LIMITED AND SUBSIDIARIES

Consolidated Condensed Statements of Comprehensive Income (Unaudited)

(in thousands)

	Three Months Ended November 30,
	2013									2012
	Before						Net of			Before						Net of
	Tax			Tax			Tax			Tax			Tax			Tax
Income	$	46,893		$	(9,369	)	$	37,524		$	43,804		$	(6,085	)	$	37,719
Other comprehensive income
Cash flow hedge activity - interest rate swaps:
Changes in fair market value	(70		)	24			(46		)	452			(158		)	294
Interest rate settlements reclassified to income	946			(330		)	616			1,000			(350		)	650
Subtotal	876			(306		)	570			1,452			(508		)	944
Cash flow hedge activity - foreign currency contracts:
Changes in fair market value	(641		)	125			(516		)	(596		)	64			(532		)
Ineffectiveness recorded in income	-			-			-			93			(15		)	78
Settlements reclassified to income	78			(15		)	63			350			(55		)	295
Subtotal	(563		)	110			(453		)	(153		)	(6		)	(159		)
Total other comprehensive income	313			(196		)	117			1,299			(514		)	785
Comprehensive income	$	47,206		$	(9,565	)	$	37,641		$	45,103		$	(6,599	)	$	38,504

	Nine Months Ended November 30,
	2013									2012
	Before						Net of			Before						Net of
	Tax			Tax			Tax			Tax			Tax			Tax
Income	$	92,880		$	(17,647	)	$	75,233		$	99,405		$	(15,246	)	$	84,159
Other comprehensive income
Cash flow hedge activity - interest rate swaps:
Changes in fair market value	(97		)	34			(63		)	(49		)	17			(32		)
Interest rate settlements reclassified to income	2,785			(975		)	1,810			2,906			(1,017		)	1,889
Subtotal	2,688			(941		)	1,747			2,857			(1,000		)	1,857
Cash flow hedge activity - foreign currency contracts:
Changes in fair market value	(673		)	136			(537		)	(619		)	73			(546		)
Ineffectiveness recorded in income	-			-			-			44			2			46
Settlements reclassified to income	(246		)	39			(207		)	313			(43		)	270
Subtotal	(919		)	175			(744		)	(262		)	32			(230		)
Total other comprehensive income	1,769			(766		)	1,003			2,595			(968		)	1,627
Comprehensive income	$	94,649		$	(18,413	)	$	76,236		$	102,000		$	(16,214	)	$	85,786

See accompanying notes to consolidated condensed financial statements.

- 5 -

HELEN OF TROY LIMITED AND SUBSIDIARIES

Consolidated Condensed Statements of Cash Flows (Unaudited)

(in thousands)

	Nine Months Ended November 30,
	2013			2012
Cash provided (used) by operating activities:
Net income	$	75,233		$	84,159
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	25,861			26,591
Provision for doubtful receivables	744			114
Non-cash share-based compensation	9,200			4,417
Intangible asset impairment charges	12,049			-
(Gain) loss on the sale of property and equipment	74			43
Deferred income taxes and tax credits	(7,136		)	(10,906		)
Changes in operating capital:
Receivables	(60,724		)	(62,955		)
Inventories	(9,018		)	(60,052		)
Prepaid expenses and other current assets	955			(512		)
Other assets and liabilities, net	(1,340		)	(469		)
Accounts payable	21,478			16,414
Accrued expenses and other current liabilities	22,787			20,574
Accrued income taxes	949			6,909
Net cash provided by operating activities	91,112			24,327
Cash provided (used) by investing activities:
Capital and intangible asset expenditures	(38,563		)	(6,405		)
Proceeds from the sale or disposal of property and equipment	-			26
Note receivable from land sale	-			737
Net cash used by investing activities	(38,563		)	(5,642		)
Cash provided (used) by financing activities:
Proceeds from line of credit	107,300			184,950
Repayment of line of credit	(184,400		)	(212,650		)
Proceeds (repayments) of long-term debt	35,509			(3,000		)
Payments of financing costs	(127		)	(28		)
Proceeds from share issuances under share-based compensation plans, including tax benefits	5,019			7,525
Payment of tax obligations resulting from issuance of restricted shares	(483		)	(108		)
Payments for repurchases of common stock	(1,311		)	(1,759		)
Share-based compensation tax benefit	1,877			661
Net cash used by financing activities	(36,616		)	(24,409		)
Net increase (decrease) in cash and cash equivalents	15,933			(5,724		)
Cash and cash equivalents, beginning balance	12,842			21,846
Cash and cash equivalents, ending balance	$	28,775		$	16,122

See accompanying notes to consolidated condensed financial statements.

- 6 -

HELEN OF TROY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Unaudited)

November 30, 2013

Note 1 - Basis of Presentation and Conventions Used in this Report

The accompanying consolidated condensed financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly our consolidated financial position as of November 30, 2013 and February 28, 2013, and the results of our consolidated operations for the three- and nine-month periods ended November 30, 2013 and 2012. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2013, and our other reports on file with the Securities and Exchange Commission (“SEC”).

In this report and the accompanying consolidated condensed financial statements and notes, unless the context suggests otherwise or otherwise indicated, references to “the Company”, “our Company”, “Helen of Troy”,  “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries, and amounts are expressed in thousands of U.S. Dollars.  We refer to the Company’s common shares, par value $0.10 per share, as “common stock.” References to “Kaz” refer to the operations of Kaz, Inc. and its subsidiaries.  References to “PUR” refer to the PUR brand of water filtration products that we acquired, along with certain other assets and liabilities, from The Procter & Gamble Company and certain of its affiliates. Kaz and PUR comprise a segment within the Company referred to as the Healthcare / Home Environment segment.  References to “OXO” refer to the operations of OXO International and certain of its affiliated subsidiaries that comprise our Housewares segment.  Product and service names mentioned in this report are used for identification purposes only and may be protected by trademarks, trade names, services marks, and/or other intellectual property rights of the Company and/or other parties in the United States and/or other jurisdictions. The absence of a specific attribution in connection with any such mark does not constitute a waiver of any such right. All trademarks, trade names, service marks, and logos referenced herein belong to their owners.  References to “the FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to U.S. generally accepted accounting principles. References to “ASC” refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB.

We are a global designer, developer, importer, marketer, and distributor of an expanding portfolio of brand-name consumer products.  We have three segments: Housewares, Healthcare / Home Environment and Personal Care.  Our Housewares segment provides a broad range of innovative consumer products for the home. Product offerings include food preparation and storage, cleaning, organization, and baby and toddler care products. The Healthcare / Home Environment segment focuses on health care devices such as thermometers, blood pressure monitors, humidifiers, and heating pads; water filtration systems; and small home appliances such as air purifiers, portable heaters, fans, and insect control devices (bug zappers).  Our Personal Care segment’s products include electric hair care, beauty care and wellness appliances; grooming tools and accessories; and liquid, solid- and powder-based personal care and grooming products. All three segments sell their products primarily through mass merchandisers, drugstore chains, warehouse clubs, catalogs, grocery stores, and specialty stores.  In addition, the Healthcare / Home Environment segment sells certain of its product lines through medical distributors and other products through home improvement stores, and the Personal Care segment sells extensively through beauty supply retailers and wholesalers. Our business is seasonal due to different calendar events, holidays, and seasonal weather patterns. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30th. We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico and the United States.

Our consolidated condensed financial statements are prepared in accordance with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates.  We have reclassified, combined or separately disclosed certain amounts in the prior period’s consolidated condensed financial statements and accompanying footnotes to conform to the current period’s presentation.

- 7 -

Note 2 – New Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the FASB or other standards setting bodies that we adopt according to the various timetables the FASB specifies.  Unless otherwise discussed, we believe the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position, results of operations and cash flows upon adoption.

Note 3 – Commitments and Contingencies

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.

Notes 7, 9, 11, 12, and 14 provide additional information regarding certain of our significant commitments and certain significant contingencies we have provided for in the accompanying consolidated condensed financial statements.

Our products are under warranty against defects in material and workmanship for periods ranging from two to five years. We estimate our warranty accrual using historical trends and believe that these trends are the most reliable method by which we can estimate our warranty liability.  The following table summarizes the activity in our warranty accrual for the periods covered in the accompanying consolidated condensed statements of income:

ACCRUAL FOR WARRANTY RETURNS

(in thousands)

	Three Months Ended November 30,						Nine Months Ended November 30,
		2013			2012			2013			2012
Beginning balance		$	21,357		$	21,860		$	23,150		$	26,665
Additions to the accrual		6,504			11,027			25,280			25,800
Reductions of the accrual - payments and credits issued		(5,770		)	(7,496)			(26,339		)	(27,074		)
Ending balance		$	22,091		$	25,391		$	22,091		$	25,391

Note 4 – Earnings per Share

We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period and diluted earnings per share using basic earnings per share plus the effect of dilutive securities. Our securities that can have dilutive effects consist of outstanding options to purchase common stock and issued and contingently issuable unvested restricted share units and awards.  See Note 14 to these consolidated condensed financial statements for more information regarding these restricted share units and awards. Options for common stock are excluded from the computation of diluted earnings per share if their effect is antidilutive.

For the periods covered in the accompanying consolidated condensed statements of income, the basic and diluted shares are as follows:

WEIGHTED AVERAGE DILUTED SECURITIES

(in thousands)

	Three Months Ended November 30,			Nine Months Ended November 30,
		2013	2012		2013	2012
Weighted average shares outstanding, basic		32,047	31,775		31,982	31,739
Incremental shares from share-based payment arrangements		435	195		329	146
Weighted average shares outstanding, diluted		32,482	31,970		32,311	31,885
Dilutive securities, as a result of in-the-money options		574	354		373	348
Dilutive securities, as a result of unvested restricted shares		408	143		298	143
Antidilutive securities, as a result of out-of-the-money options		358	612		586	618

- 8 -

Note 5 – Segment Information

The following tables contain segment information for the periods covered in the accompanying consolidated condensed statements of income:

THREE MONTHS ENDED NOVEMBER 30, 2013 AND 2012

(in thousands)

			Healthcare /		Personal
November 30, 2013	Housewares		Home Environment		Care		Total
Sales revenue, net	$	74,776	$	165,752	$	140,202	$	380,730
Asset impairment charges	-		-		-		-
Operating income	15,278		10,665		23,450		49,393
Capital and intangible asset expenditures	193		3,207		585		3,985
Depreciation and amortization	897		5,349		2,726		8,972
			Healthcare /		Personal
November 30, 2012	Housewares		Home Environment		Care		Total
Sales revenue, net	$	67,787	$	158,174	$	148,638	$	374,599
Operating income	13,927		11,323		21,802		47,052
Capital and intangible asset expenditures	118		230		297		645
Depreciation and amortization	1,177		4,376		3,243		8,796
NINE MONTHS ENDED NOVEMBER 30, 2013 AND 2012
(in thousands)
			Healthcare /		Personal
November 30, 2013	Housewares		Home Environment		Care		Total
Sales revenue, net	$	208,471	$	424,398	$	371,764	$	1,004,633
Asset impairment charges	-		-		12,049		12,049
Operating income	41,506		22,175		36,693		100,374
Capital and intangible asset expenditures	574		36,321		1,668		38,563
Depreciation and amortization	2,946		14,897		8,018		25,861
			Healthcare /		Personal
November 30, 2012	Housewares		Home Environment		Care		Total
Sales revenue, net	$	192,606	$	391,061	$	378,554	$	962,221
Operating income	37,282		26,197		45,562		109,041
Capital and intangible asset expenditures	635		2,354		3,416		6,405
Depreciation and amortization	3,753		13,086		9,752		26,591

We compute operating income for each segment based on net sales revenue, less cost of goods sold, selling, general and administrative expense (“SG&A”), and any asset impairment charges associated with the segment. The SG&A used to compute each segment’s operating income is directly associated with the segment, plus overhead expenses that are allocable to the segment. We make allocations of overhead between operating segments using a number of relevant allocation criteria, depending on the nature of the expense, the most significant of which are relative revenues, estimates of relative labor expenditures, headcount, and facility square footage.  We do not allocate nonoperating income and expense, including interest or income taxes to operating segments.

- 9 -

Note 6 – Comprehensive Loss

The components of accumulated other comprehensive loss, net of tax, are as follows:

COMPONENTS OF ACCUMULATED OTHER COMPREHENSIVE LOSS

(in thousands)

	November 30,			February 28,
	2013			2013
Unrealized holding losses on cash flow hedges - interest rate swap, net of tax (1)	$	(1,388	)	$	(3,135	)
Unrealized holding gains (losses) on cash flow hedges - foreign currency contracts, net of tax (2)	(338		)	406
Total accumulated other comprehensive loss	$	(1,726	)	$	(2,729	)

(1)  Includes net deferred tax benefits of $0.75 and $1.69 million at November 30, 2013 and February 28, 2013, respectively.

(2)  Includes net deferred tax benefits (expense) of $0.09 and ($0.09) million at November 30, 2013 and February 28, 2013, respectively.

Note 7 – Supplemental Balance Sheet Information

PROPERTY AND EQUIPMENT

(in thousands)

	Estimated
	Useful Lives	November 30,			February 28,
	(Years)	2013			2013
Land	-	$	12,800		$	12,800
Building and improvements	3 - 40	98,469			66,994
Computer, furniture and other equipment	3 - 15	60,002			58,284
Tools, molds and other production equipment	1 - 10	28,738			29,264
Construction in progress	-	5,144			9,149
Property and equipment, gross		205,153			176,491
Less accumulated depreciation		(74,576		)	(74,775		)
Property and equipment, net		$	130,577		$	101,716

Property and equipment includes cumulative capital expenditures of $35.22 and $4.03 million as of November 30, 2013 and February 28, 2013, respectively, in connection with our new 1.3 million square foot distribution facility on approximately 84 acres of land in Olive Branch, Mississippi.  The new facility will consolidate the operations of our U.S. based Personal Care and Healthcare / Home Environment appliance businesses.  The new facility became operational for the Healthcare / Home Environment segment during the first week of September 2013.  We expect to complete the transition of our domestic Personal Care appliance distribution to the new facility in the first quarter of fiscal year 2015.  Remaining capital expenditure commitments in connection with the Personal Care appliance move are not expected to be material.  See Note 9 to these consolidated condensed financial statements for related information regarding the debt incurred to fund the construction of the new distribution facility.

- 10 -

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

(in thousands)

	November 30,		February 28,
	2013		2013
Accrued compensation, benefits and payroll taxes	$	44,478	$	34,265
Accrued sales returns, discounts and allowances	35,096		22,561
Accrued warranty returns	22,091		23,150
Accrued advertising	23,561		14,554
Accrued product liability, legal and professional fees	6,384		9,061
Accrued royalties	7,639		7,731
Accrued property, sales and other taxes	8,083		5,729
Derivative liabilities, current	2,559		3,044
Other	8,645		13,968
Total accrued expenses and other current liabilities	$	158,536	$	134,063

OTHER LIABILITIES, NON-CURRENT

(in thousands)

	November 30,		February 28,
	2013		2013
Deferred compensation liability	$	7,908	$	6,443
Liability for uncertain tax positions	15,524		15,759
Derivative liabilities	-		1,780
Other liabilites	1,115		1,760
Total other liabilities, non-current	$	24,547	$	25,742

Note 8 – Goodwill and Intangible Assets

Annual Impairment Testing in the First Quarter of Fiscal Year 2014 - We performed our annual evaluation of goodwill and indefinite-lived intangible assets for impairment during the first quarter of fiscal year 2014.  As a result of our testing of indefinite-lived trademarks and licenses, we recorded a non-cash asset impairment charge of $12.05 million ($12.03 million after tax).  The charge was related to certain trademarks in our Personal Care segment, which were written down to their estimated fair value, determined on the basis of future discounted cash flows using the relief from royalty valuation method.

Annual Impairment Testing in the First Quarter of Fiscal Year 2013 - We performed our annual evaluation of goodwill and indefinite-lived intangible assets for impairment during the first quarter of fiscal year 2013.   As a result, we concluded no asset impairment charges were required.  For fiscal year 2013, the estimated fair value of the indefinite-lived trademarks and licenses, reporting unit net assets and the Company’s estimated enterprise value exceeded their respective carrying values as of the date of the evaluation.

- 11 -

A summary of the carrying amounts and associated accumulated amortization for all intangible assets by operating segment follows:

GOODWILL AND INTANGIBLE ASSETS

(in thousands)

	November 30, 2013										February 28, 2013
	Gross		Cumulative								Gross		Cumulative
	Carrying		Goodwill			Accumulated			Net Book		Carrying		Goodwill			Accumulated			Net Book
Description	Amount		Impairments			Amortization			Value		Amount		Impairments			Amortization			Value
Housewares:
Goodwill	$	166,132	$	-		$	-		$	166,132	$	166,132	$	-		$	-		$	166,132
Trademarks - indefinite	75,200		-			-			75,200		75,200		-			-			75,200
Other intangibles - finite	15,794		-			(10,950		)	4,844		15,609		-			(10,070		)	5,539
Total Housewares	257,126		-			(10,950		)	246,176		256,941		-			(10,070		)	246,871
Healthcare / Home Environment:
Goodwill	251,758		-			-			251,758		251,758		-			-			251,758
Trademarks - indefinite	54,000		-			-			54,000		54,000		-			-			54,000
Licenses - finite	15,300		-			(5,676		)	9,624		15,300		-			(3,455		)	11,845
Other Intangibles - finite	114,490		-			(31,833		)	82,657		114,490		-			(23,220		)	91,270
Total Healthcare / Home Environment	435,548		-			(37,509		)	398,039		435,548		-			(26,675		)	408,873
Personal Care:
Goodwill	81,841		(46,490		)	-			35,351		81,841		(46,490		)	-			35,351
Trademarks - indefinite	63,754		-			-			63,754		75,803		-			-			75,803
Trademarks - finite	150		-			(76		)	74		150		-			(72		)	78
Licenses - indefinite	10,300		-			-			10,300		10,300		-			-			10,300
Licenses - finite	18,683		-			(15,807		)	2,876		18,683		-			(15,570		)	3,113
Other intangibles - finite	49,437		-			(25,162		)	24,275		49,437		-			(20,957		)	28,480
Total Personal Care	224,165		(46,490		)	(41,045		)	136,630		236,214		(46,490		)	(36,599		)	153,125
Total	$	916,839	$	(46,490	)	$	(89,504	)	$	780,845	$	928,703	$	(46,490	)	$	(73,344	)	$	808,869

The following table summarizes the amortization expense attributable to intangible assets for the periods covered in the accompanying consolidated condensed statements of income, as well as our estimated amortization expense for the fiscal years 2014 through 2019.

AMORTIZATION OF INTANGIBLE ASSETS

(in thousands)

Aggregate Amortization Expense
For the three months ended
November 30, 2013	$	5,407
November 30, 2012	$	5,538

Aggregate Amortization Expense
For the nine months ended
November 30, 2013	$	16,246
November 30, 2012	$	16,800

Estimated Amortization Expense
For the fiscal years ended
February 2014	$	21,556
February 2015	$	21,030
February 2016	$	20,847
February 2017	$	20,523
February 2018	$	16,703
February 2019	$	11,962

- 12 -

Note 9 – Debt

Revolving Line of Credit - We have a Credit Agreement (the “Credit Agreement”) with Bank of America, N.A. that provides for an unsecured total revolving commitment of up to $250.00 million. The commitment under the Credit Agreement terminates on December 30, 2015.  Borrowings accrue interest under one of two alternative methods as described in the Credit Agreement.  With each borrowing against our credit line, we can elect the interest rate method based on our funding needs at the time.  We also incur loan commitment fees and letter of credit fees under the Credit Agreement.  Outstanding letters of credit reduce the borrowing availability under the Credit Agreement on a dollar-for-dollar basis.  As of November 30, 2013, the outstanding revolving loan principal balance was $4.90 million and there were $0.28 million of open letters of credit outstanding against the Credit Agreement. For the three- and nine-months ended November 30, 2013, borrowings under the Credit Agreement incurred interest charges at rates ranging from 1.17 to 3.25 percent and 1.17 to 3.63 percent, respectively.  For both the three- and nine-months ended November 30, 2012, borrowings under the Credit Agreement incurred interest charges at rates ranging from 1.59 to 4.00 percent.  As of November 30, 2013, the amount available for borrowings under the Credit Agreement was $244.82 million.

Long-Term Debt – A summary of our long-term debt is as follows:

LONG-TERM DEBT

(dollars in thousands)

	Original
	Date	Interest		November 30,			February 28,
	Borrowed	Rates	Matures	2013			2013
$38 million unsecured loan with a state industrial development corporation, interim draws, interest is set and payable quarterly at the Base Rate, as defined below, plus a margin of up to 1.125%, or applicable LIBOR plus a margin of up to 2.125%, as determined by the interest rate elected. Loan subject to holder’s call on or after March 1, 2018. Loan can be prepaid without penalty any
time after March 20, 2014.	03/13	1.17%	03/23	$	35,509		$	-
$75 million unsecured floating interest rate 10 year Senior Notes. Interest set and payable quarterly at three-month LIBOR plus 90 basis points. Principal is due in June 2014. Notes can be prepaid without penalty. (1)	06/04	6.01%	06/14	75,000			75,000
$100 million unsecured Senior Notes payable at a fixed interest rate of 3.90%. Interest payable semi-annually. Annual principal payments of $20 million begin in January 2014. Prepayment of notes are subject to a “make whole” premium.	01/11	3.90%	01/18	100,000			100,000
Total long-term debt				210,509			175,000
Less current maturities of long-term debt				(96,900		)	(20,000		)
Long-term debt, excluding current maturities				$	113,609		$	155,000

(1)Floating interest rates have been hedged with an interest rate swap to effectively fix interest rates. Additional information regarding the swap is provided in Note 12 to these consolidated condensed financial statements.

In March 2013, Kaz USA, Inc. (“Kaz USA”), a wholly owned subsidiary of the Company, entered into a Loan Agreement, dated as of March 1, 2013, with the Mississippi Business Finance Corporation (the “MBFC”) in connection with the issuance by the MBFC of up to $38.00 million of taxable industrial development revenue bonds (the “Bonds”). The Bonds are issued under a Trust Indenture (the “IRB Indenture”), between the MBFC and Deutsche Bank National Trust Company, as trustee.  Interim draws, accumulating up to a $38.00 million aggregate maximum, may be made through March 20, 2014.  The Bonds and the related loan to Kaz USA (the “MBFC Loan”) will bear interest at a variable rate as elected by Kaz USA equal to either (a) a “Base Rate” plus a margin of 0.00 to 1.125 percent, depending upon the leverage ratio at the time of the borrowing or (b) the respective one-, two-, three-, or six-month LIBOR rate plus 1.00 to 2.125 percent, depending upon the leverage ratio at the time of the borrowing.  The Base Rate is equal to the highest of  (i) the federal funds rate for the day, plus 0.50 percent, (ii) the prime rate of Bank of America, N.A., or (iii) the respective one-, two-, three-, or six-month LIBOR rate plus 1.00 percent.  The proceeds of the MBFC Loan have been used by Kaz USA to finance the purchase of land, construction of a distribution facility and the acquisition and installation of equipment, machinery and related assets located in Olive Branch, Mississippi.

- 13 -

Assuming the $38.00 million aggregate maximum is borrowed, outstanding principal of the MBFC Loan will be payable as follows: $1.90 million on March 1 in each of 2014, 2015, 2018, 2019, 2020, 2021 and 2022; $3.80 million on March 1, 2016; $5.70 million on March 1, 2017; and $15.20 million on March 1, 2023. Any remaining outstanding principal and interest is due upon maturity on March 1, 2023.  The MBFC Loan may be prepaid in whole or part without penalty any time after March 20, 2014.  Additionally, Bank of America, N.A., the purchaser of the Bonds, may elect for the MBFC Loan to be prepaid in full on March 1, 2018.  Following March 1, 2018, Bank of America, N.A. may elect for the MBFC Loan to be prepaid on March 1 of each subsequent year prior to maturity upon at least 90 days notice. In lieu of any prepayment, the Bonds may be purchased by a transferee, as permitted under the IRB Indenture.

The fair market value of the fixed rate debt at November 30, 2013, computed using a discounted cash flow analysis, was $104.96 million compared to the $100.00 million book value and represents a Level 2 liability. All other long-term debt has floating interest rates, and its book value approximates its fair value at November 30, 2013.

All of our debt is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries. Our debt agreements require the maintenance of certain financial covenants, including maximum leverage ratios, minimum interest coverage ratios and minimum consolidated net worth levels (as each of these terms is defined in the various agreements).  Our debt agreements also contain other customary covenants, including, among other things, covenants restricting or limiting the Company, except under certain conditions set forth therein, from (1) incurring debt, (2) incurring liens on its properties, (3) making certain types of investments, (4) selling certain assets or making other fundamental changes relating to mergers and consolidations, and (5) repurchasing shares of our common stock and paying dividends.

As of November 30, 2013, our debt agreements effectively limited our ability to incur more than $376.58 million of additional debt from all sources, including draws on the Credit Agreement. As of November 30, 2013, we were in compliance with the terms of all of our debt agreements.

Note 10 – Income Taxes

Income tax expense for the three- and nine-month periods ended November 30, 2013 was 20.0 and 19.0 percent of income before income taxes, respectively, compared to 13.9 and 15.3 percent, respectively, for the same periods last year.  The year-over-year comparison of our effective tax rate for the quarter was impacted by discrete items that were a benefit to tax expense in the third quarter of the prior fiscal year, and shifts in the mix of taxable income between our various tax jurisdictions. Our effective tax rate for the nine months ended November 30, 2013 was also impacted by asset impairment charges of $12.05 million recorded in the first quarter of fiscal year 2014, for which the related tax benefit was only $0.02 million.

- 14 -

Note 11 – Fair Value

The fair value hierarchy of our financial assets and liabilities carried at fair value and measured on a recurring basis is as follows:

FAIR VALUES OF FINANCIAL ASSETS AND LIABILITIES

(in thousands)

			Quoted Prices in		Significant Other
			Active Markets		Observable
	Fair Values at		for Identical Assets		Market Inputs
Description	November 30, 2013		(Level 1)		(Level 2)
Assets:
Money market accounts	$	1,116	$	1,116	$	-
Total assets	$	1,116	$	1,116	$	-
Liabilities:
Long-term debt - fixed rate (1)	$	104,964	$	-	$	104,964
Long-term debt - floating rate	110,509		-		110,509
Interest rate swaps and foreign currency contracts	2,559		-		2,559
Total liabilities	$	218,032	$	-	$	218,032
			Quoted Prices in		Significant Other
			Active Markets		Observable
	Fair Values at		for Identical Assets		Market Inputs
Description	February 28, 2013		(Level 1)		(Level 2)
Assets:
Money market accounts	$	1,091	$	1,091	$	-
Foreign currency contracts	496		-		496
Total assets	$	1,587	$	1,091	$	496
Liabilities:
Long-term debt - fixed rate (1)	$	105,725	$	-	$	105,725
Long-term debt - floating rate	75,000		-		75,000
Interest rate swaps	4,824		-		4,824
Total liabilities	$	185,549	$	-	$	185,549

(1)Debt values are reported at estimated fair value in these tables, but are recorded in the accompanying consolidated condensed balance sheets at the undiscounted value of remaining principal payments due.

The carrying amounts of cash and cash equivalents, receivables and accounts payable approximate fair value because of the short maturity of these items.  Money market accounts are included in cash and cash equivalents in the accompanying consolidated condensed balance sheets and are classified as Level 1 assets.

We classify our fixed and floating rate debt as Level 2 liabilities because the estimation of the fair market value of these financial liabilities requires the use of discount rates based upon current market rates of interest for debt with comparable remaining terms. Such comparable rates are significant other observable market inputs. The fair market value of the fixed rate debt was computed using a discounted cash flow analysis and discount rates of 1.49 percent at November 30, 2013 and 1.83 percent February 28, 2013. All other long-term debt has floating interest rates, and its book value approximates its fair value as of the reporting date.

We use derivatives for hedging purposes and our derivatives are primarily foreign currency contracts and an interest rate swap. We determine the fair value of our derivative instruments based on Level 2 inputs in the fair value hierarchy. See Note 12 to these consolidated condensed financial statements for more information on our hedging activities.

- 15 -

The Company’s other non-financial assets include goodwill and other intangible assets, which we classify as Level 3 assets. These assets are measured at fair value on a non-recurring basis as part of the Company’s impairment assessments and as circumstances require. As discussed in Note 8, in connection with our annual impairment testing during the fiscal quarter ended May 31, 2013, we recorded a non-cash asset impairment charge of $12.05 million ($12.03 million after tax).  The charge related to certain trademarks in our Personal Care segment, which were written down to their estimated fair value, determined on the basis of future discounted cash flows using the relief from royalty valuation method.

Note 12 – Financial Instruments and Risk Management

Foreign Currency Risk - Our functional currency is the U.S. Dollar. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”).  Such transactions include sales, certain inventory purchases and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies.  During the three- and nine-month periods ended November 30, 2013, approximately 16 and 15 percent, respectively, of our net sales revenue was in foreign currencies.  During the three- and nine-month periods ended November 30, 2012, approximately 18 and 17 percent, respectively, of our net sales revenue was in foreign currencies.  These sales were primarily denominated in British Pounds, Euros, Mexican Pesos, Canadian Dollars, Australian Dollars, Peruvian Soles, and Venezuelan Bolivares Fuertes. We make most of our inventory purchases from the Far East and use the U.S. Dollar for such purchases.  In our consolidated condensed statements of income, exchange gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets, and deferred tax liabilities, are recognized in their respective income tax lines, and all other foreign exchange gains and losses from remeasurement are recognized in SG&A.  For the three- and nine-month periods ended November 30, 2013, we recorded net foreign exchange gains (losses), including the impact of currency hedges, of $0.17 and ($0.33) million, respectively, in SG&A and ($0.19) and ($0.17) million, respectively, in income tax expense.  For the three- and nine-month periods ended November 30, 2012, we recorded net foreign exchange gains (losses), including the impact of currency hedges and currency swaps, of ($0.06) and ($0.23) million, respectively, in SG&A and ($0.07) and $0.10 million, respectively, in income tax expense.

We have historically hedged against certain foreign currency exchange rate risk by using a series of forward contracts designated as cash flow hedges to protect against the foreign currency exchange risk inherent in our forecasted transactions denominated in currencies other than the U.S. Dollar.  We do not enter into any forward exchange contracts or similar instruments for trading or other speculative purposes.

Interest Rate Risk – Interest on our outstanding debt as of November 30, 2013 is both floating and fixed.  Fixed rates are in place on $100.00 million of Senior Notes at 3.90 percent, while floating rates are in place on $4.90 million of borrowings under our Credit Agreement, $35.51 million of interim draws under our MBFC Loan and $75.00 million of Senior Notes due June 2014.  If short-term interest rates increase, we will incur higher interest rates on any outstanding balances under the Credit Agreement and MBFC Loan. The floating rate Senior Notes due June 2014 reset as described in Note 9, and have been effectively converted to fixed rate debt using an interest rate swap (the “swap”), as described below.

We manage our floating rate $75.00 million of Senior Notes due June 2014 using an interest rate swap.  As of November 30, 2013, the swap converted an aggregate notional principal amount of $75.00 million from floating interest rate payments under our Senior Notes due June 2014 to fixed interest rate payments at 6.01 percent.  In the swap transaction, we maintain contracts to pay fixed rates of interest on an aggregate notional principal amount of $75.00 million at a rate of 5.11 percent on our Senior Notes due June 2014, while simultaneously receiving floating rate interest payments set at 0.25 percent as of November 30, 2013 on the same notional amounts.  The fixed rate side of the swap will not change over its life.  The floating rate payments are reset quarterly based on three month LIBOR.  The resets are concurrent with the interest payments made on the underlying debt. Changes in the spread between the fixed rate payment side of the swap and the floating rate receipt side of the swap offset 100 percent of the change in any period of the underlying debt’s floating rate payments.  The swap is used to reduce our risk of increased interest costs; however, when interest rates drop significantly below the swap rate, we lose the benefit that our floating rate debt would provide, if not managed with a swap. The swap is considered 100 percent effective.

- 16 -

The fair values of our various derivative instruments are as follows:

FAIR VALUES OF DERIVATIVE INSTRUMENTS

(in thousands)

November 30, 2013
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Non-current
Foreign currency contracts - sell Euro	Cash flow	6/2014	€	6,350	$	-	$	107	$	-
Foreign currency contracts - sell Pounds	Cash flow	8/2014	£	5,250	-		316		-
Interest rate swap	Cash flow	6/2014	$	75,000	-		2,136		-
Total fair value					$	-	$	2,559	$	-

February 28, 2013
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Non-current
Foreign currency contracts - sell Euro	Cash flow	10/2013	€	7,050	$	239	$	-	$	-
Foreign currency contracts - sell Pounds	Cash flow	11/2013	£	3,000	257		-		-
Interest rate swap	Cash flow	6/2014	$	75,000	-		3,044		1,780
Total fair value					$	496	$	3,044	$	1,780

The pre-tax effect of derivative instruments for the periods covered in the accompanying consolidated condensed financial statements are as follows:

PRE-TAX EFFECT OF DERIVATIVE INSTRUMENTS

(in thousands)

	Three Months Ended November 30,
	Gain / (Loss)						Gain / (Loss) Reclassified
	Recognized in OCI						from Accumulated Other							Gain / (Loss) Recognized
	(effective portion)						Comprehensive Loss into Income							as Income (1)
	2013			2012			Location	2013			2012			Location	2013		2012
Currency contracts - cash flow hedges	$	(641	)	$	(596	)	SG&A	$	(78	)	$	(350	)	SG&A	$	-	$	(93	)
Interest rate swaps - cash flow hedges	(70		)	452			Interest expense	(946		)	(1,000		)		-		-
Total	$	(711	)	$	(144	)		$	(1,024	)	$	(1,350	)		$	-	$	(93	)

	Nine Months Ended November 30,
	Gain / (Loss)						Gain / (Loss) Reclassified
	Recognized in OCI						from Accumulated Other							Gain / (Loss) Recognized
	(effective portion)						Comprehensive Loss into Income							as Income (1)
	2013			2012			Location	2013			2012			Location	2013		2012
Currency contracts - cash flow hedges	$	(673	)	$	(619	)	SG&A	$	246		$	(313	)	SG&A	$	-	$	(44	)
Interest rate swaps - cash flow hedges	(97		)	(49		)	Interest expense	(2,785		)	(2,906		)		-		-
Total	$	(770	)	$	(668	)		$	(2,539	)	$	(3,219	)		$	-	$	(44	)

(1)  The amount shown represents the ineffective portion of the change in fair value of a cash flow hedge.

We expect net losses of $0.42 million associated with foreign currency contracts and $2.14 million associated with our interest rate swap, currently reported in accumulated other comprehensive loss, to be reclassified into income over the next nine months. The amount ultimately realized, however, will differ as exchange rates and interest rates change and the underlying contracts settle.

- 17 -

Counterparty Credit Risk - Financial instruments, including foreign currency contracts and interest rate swaps, expose us to counterparty credit risk for nonperformance.  We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments.  Although our theoretical credit risk is the replacement cost at the then-estimated fair value of these instruments, we believe that the risk of incurring credit risk losses is remote.

Note 13 – Repurchase of Helen of Troy Common Stock

As of November 30, 2013, we were authorized by our Board of Directors to purchase up to 2,910,487 shares of common stock in the open market or through private transactions.  Our current equity compensation plans include provisions that allow for the “net exercise” of stock options by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option holder can be paid for by having the option holder tender back to the Company a number of shares at fair value equal to the amounts due. Net exercises are accounted for by the Company as a purchase and retirement of shares.

During the fiscal quarter ended May 31, 2013, our Chief Executive Officer and President (the “CEO”) tendered 9,898 shares of restricted common stock having a market value of $0.35 million as payment for related federal tax obligations arising from the vesting and settlement of performance-based restricted share units (“Performance RSUs”). We accounted for this activity as a purchase and retirement of the shares at a price of $35.55 per share.

For the periods covered in the accompanying consolidated condensed financial statements, open market repurchase activity and common stock option exercises resulted in the following share repurchases:

SHARE REPURCHASES
	Three Months Ended November 30,				Nine Months Ended November 30,
	2013		2012		2013		2012
Common stock repurchased on the open market
Number of shares	-		61,426		33,862		61,426
Aggregate market value of shares (in thousands)	$	-	$	1,759	$	1,311	$	1,759
Average price per share	$	-	$	28.64	$	38.71	$	28.64
Common stock received in settlement of stock options and Performance RSUs
Number of shares	-		1,752		13,453		48,791
Aggregate market value of shares (in thousands)	$	-	$	58	$	490	$	1,615
Average price per share	$	-	$	33.18	$	36.44	$	33.11

Note 14 – Share-Based Compensation Plans

We have share-based awards outstanding under two expired and three active share-based compensation plans.

During the three- and nine-months ended November 30, 2013, the Company granted options to purchase 4,000 and 262,750 shares of common stock, respectively, to certain of our officers, employees and new hires.  For the fiscal year-to-date, these options were granted at exercise prices ranging from $36.03 to $46.38 per share.  The fair values of the options were estimated using the Black-Scholes option pricing model to estimate fair values ranging from $10.82 to $13.39 for grants with terms of four and five years.  The following assumptions were used for the grants: expected lives ranging from 4.05 to 4.35 years; risk-free interest rates ranging from 0.55 to 1.14 percent; zero dividend yield; and expected volatilities ranging from 34.87 to 41.67 percent.

During the three- and nine-month periods ending November 30, 2013, the Company awarded restricted stock grants with total values of $0.15  and $0.44  million, respectively, to certain Board members based upon fair values at the date of grant ranging from $36.56 to $40.23, respectively.  Over the same three- and nine-month periods, the grants were settled with 2,628 and 7,884 restricted shares, respectively, and cash of $0.05 and $0.13 million, respectively.  The restricted stock awards vested immediately.

- 18 -

In the first quarter of fiscal year 2014, under the terms of his employment agreement, bonus plan and relevant stock plans, our CEO earned and received the following equity awards as a component of his fiscal year 2013 performance-based incentive compensation:

·159,666 shares of restricted stock with a total grant date fair value of $5.68 million, or $35.55 per share, which vest on February 28, 2015; and

·100,000 Performance RSUs, originally granted on March 1, 2012 with an original grant date fair market value of $3.29 million, or $32.88 per share, of which 33,400 shares vested on April 22, 2013, 33,300 shares vest on February 28, 2014 and 33,300 shares vest on February 28, 2015.

We are recording the expense for these awards in accordance with their vesting over their related service periods.

Accruals for the CEO’s remaining Performance RSUs and the CEO’s restricted stock awards associated with his annual bonus are subject to the achievement of specified performance goals for the fiscal year and are estimated until earned, subject to a probability assessment of achieving the associated performance criteria.  These accruals and the service period expense associated with the CEO’s fiscal year 2013 and 2014 awards are shown in the line below entitled “Performance-based restricted stock awards and units.”

During the three- and nine-months ended November 30, 2013, employees and directors exercised stock options to purchase 17,139 and 170,859 shares of common stock, respectively.  During the nine months ended November 30, 2013, employees purchased 20,028 shares of common stock through our Employee Stock Purchase Plan.

We recorded share-based compensation expense in SG&A for the periods covered in the accompanying consolidated condensed financial statements as follows:

SHARE-BASED PAYMENT EXPENSE

(in thousands, except per share data)

	Three Months Ended November 30,				Nine Months Ended November 30,
	2013		2012		2013		2012
Stock options	$	589	$	572	$	1,791	$	1,731
Directors stock compensation	151		120		438		357
Performance-based restricted stock awards and units	1,708		701		6,944		2,296
Employee stock purchase plan	-		2		158		140
Share-based payment expense	2,448		1,395		9,331		4,524
Less income tax benefits	(466)		(203)		(1,877)		(661		)
Share-based payment expense, net of income tax benefits	$	1,982	$	1,192	$	7,454	$	3,863
Earnings per share impact of share-based payment expense:
Basic	$	0.06	$	0.04	$	0.23	$	0.12
Diluted	$	0.06	$	0.04	$	0.23	$	0.12

- 19 -

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This discussion contains a number of forward-looking statements, all of which are based on current expectations. Actual results may differ materially due to a number of factors, including those discussed in Part I, Item 3. “Quantitative and Qualitative Disclosures about Market Risk” and “Information Regarding Forward-Looking Statements” in this report and “Risk Factors” in the Company’s most recent annual report on Form 10-K and its other filings with the Securities and Exchange Commission (the “SEC”).  This discussion should be read in conjunction with our consolidated condensed financial statements included under Part I, Item 1 of this report.

OVERVIEW OF RESULTS:

We operate our business under three segments: Housewares, Healthcare / Home Environment and Personal Care. Our Housewares segment reports the operations of OXO, whose product offerings include food preparation and storage, cleaning, organization, and baby and toddler care products. The Healthcare / Home Environment segment sells products in the following categories: health care devices, such as thermometers, blood pressure monitors, humidifiers, and heating pads; water filtration systems; and small home appliances, such as air purifiers, portable heaters, fans, and insect control devices (bug zappers).  Our Personal Care segment currently offers products in three categories: hair care, beauty care and wellness appliances; grooming, skin care and hair care solutions; and brushes, combs and accessories.

Our business is seasonal due to different calendar events, holidays, and seasonal weather patterns. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30th.

Our business is dependent upon discretionary consumer demand for most of our products and our business primarily operates within mature and highly developed consumer markets. The principal driver of our operating performance is the strength of the U.S. retail economy, as approximately 77 percent of our fiscal 2014 year-to-date net sales revenue is from U.S. shipments.  Domestic macroeconomic conditions have been slowly improving and lately we have begun to see indications of economic improvement in key Western European and Latin American markets.  While favorable domestic economic indicators exist, including a robust stock market, moderating fuel prices, modestly positive employment figures, an uptick in manufacturing and recovering domestic housing markets, we continue to believe consumers remain cautious with their disposable personal income. We are also uncertain regarding the mid and long-term impact of the recent expiration of payroll tax reductions, the expiration of extended unemployment benefits, the expiration of a temporary boost in food stamp benefits, and lack of clarity for many consumers regarding their personal health care costs. The 2013 U.S. retail holiday season has been highly promotional with such activity beginning almost immediately after Halloween. The retail holiday selling season was also the shortest in over a decade with 26 days between Thanksgiving and Christmas this year, compared to 32 days last year.  Though unemployment rates have dropped domestically and in certain key international markets, we remain cautious regarding the current and long-term strength of the middle class and consumer demand due to the impact of shifting demographics and displacement of workers from the last recession.  Finally, certain underlying global dynamics that we believe have kept consumers and businesses unsettled still remain: Middle East tensions and related political instabilities, long-term U.S. government fiscal issues, uncertainty regarding domestic tax policy, cost variability, and frequent supplier instabilities.  Accordingly, we remain cautious regarding our business outlook.

We have made the following progress on key initiatives:

·The Healthcare / Home Environment segment converted from its legacy Enterprise Resource Planning (“ERP”) system onto our global ERP system.  We believe this migration will eliminate a number of inefficiencies associated with managing multiple ERP systems and continue to improve uniformity of execution throughout our organization.   In addition, we are constantly upgrading and adding functionality to the overall system with key enhancements underway in the product development and finance areas that will further streamline and improve the quality of our back office operations.

- 20 -

·We commenced shipments out of our new 1.3 million square foot distribution facility in Olive Branch, Mississippi during the first week of September 2013.  The new facility will ultimately house the distribution operations of both our Personal Care and Healthcare / Home Environment appliance businesses.  We have moved the domestic Healthcare / Home Environment distribution operation out of its current leased Memphis, Tennessee location and have exited that facility.  We expect to complete the transition of our domestic Personal Care appliance distribution operation to the new facility in the first quarter of fiscal year 2015.  The project remains on schedule and on budget.

These investments will improve the infrastructure that supports our current business, stage us for additional operating efficiencies over the foreseeable future and provide a platform for further growth.

Consolidated net sales revenue for the three- and nine-month periods ended November 30, 2013 increased$6.13 and $42.41 million to $380.73 and $1,004.63 million, respectively, compared to $374.60 and $962.22million, respectively, for the same periods last year.  Net sales revenue in our Housewares segment increased $6.99 million, or 10.3 percent, for the three months ended November 30, 2013, and increased $15.87 million, or 8.2 percent, for the nine months ended November 30, 2013, when compared to the same periods last year.  Net sales revenue in our Healthcare / Home Environment segment increased $7.58 million, or 4.8 percent, for the three months ended November 30, 2013, and increased $33.34 million, or 8.5 percent, for the nine months ended November 30, 2013, when compared to the same periods last year.  Net sales revenue in our Personal Care segment decreased $8.44 million, or 5.7 percent, for the three months ended November 30, 2013, and decreased $6.79 million, or 1.8 percent, for the nine months ended November 30, 2013, when compared to the same periods last year.  In addition to our net sales revenue performance discussed above, key results for the three- and nine-month periods ended November 30, 2013 include the following:

·Consolidated gross profit margin as a percentage of net sales revenue for the fiscal quarter ended November 30, 2013 decreased 0.8 percentage points to 38.8 percent compared to 39.6 percent for the same period last year. Consolidated gross profit margin as a percentage of net sales revenue for the nine month period ended November 30, 2013 decreased 1.3 percentage points to 38.9 percent compared to 40.2 percent for the same period last year.

·Selling, general and administrative expense (“SG&A”) as a percentage of net sales revenue decreased 1.3 percentage points to 25.8 percent for the three months ended November 30, 2013 compared to 27.1 percent for the same period last year. SG&A as a percentage of net sales revenue for the nine month period ended November 30, 2013 decreased 1.1 percentage points to 27.7 percent compared to 28.8 percent for the same period last year.

·For the three months ended November 30, 2013, operating income increased $2.34 million, or 5.0 percent, to $49.39 million compared to $47.05 million for the same period last year.  For the nine months ended November 30, 2013, operating income decreased $8.67 million, or 7.9 percent, to $100.37 million compared to $109.04 million for the same period last year. Operating income for the nine month period ended November 30, 2013 includes a non-cash asset impairment charge of $12.05 million, which represents an 11.0 percent decline in operating income, year-over-year.   We recorded no non-cash asset impairment charges during the same period last year.

·For the three- and nine-month periods ended November 30, 2013, our net income was $37.52 and $75.23 million, respectively, compared to $37.72 and $84.16 million, respectively, for the same periods last year, a decrease of 0.5 and 10.6 percent, respectively. For the three- and nine-month periods ended November 30, 2013, our diluted earnings per share was $1.16 and $2.33 compared to $1.18 and $2.64, respectively, for the same periods last year.

·Income without impairments was $87.27 million for the nine months ended November 30, 2013, compared to $84.16 million for the same period last year.  Our diluted earnings per share without impairments was $2.70 for the nine months ended November 30, 2013, compared to $2.64 for the same period last year.  Income without impairments and diluted earnings per share without impairments are non-GAAP financial measures as set forth in SEC Regulation G, Rule 100.  These measures are discussed further, and reconciled to their applicable GAAP-based measures, beginning on page 29.

- 21 -

RESULTS OF OPERATIONS

The following table sets forth, for the periods indicated, our selected operating data, in U.S. Dollars, as a year-over-year percentage change and as a percentage of net sales revenue.  We will refer to this table in the discussion of results of operations which follows:

SELECTED OPERATING DATA

(dollars in thousands)

	Three Months Ended November 30,									% of Sales Revenue, net
		2013			2012		$ Change		% Change	2013	2012
Sales revenue by segment, net
Housewares		$	74,776		$	67,787	$	6,989	10.3%	19.6%	18.1%
Healthcare / Home Environment		165,752			158,174		7,578		4.8%	43.5%	42.2%
Personal Care		140,202			148,638		(8,436)		-5.7%	36.8%	39.7%
Total sales revenue, net		380,730			374,599		6,131		1.6%	100.0%	100.0%
Cost of goods sold		233,029			226,146		6,883		3.0%	61.2%	60.4%
Gross profit		147,701			148,453		(752)		-0.5%	38.8%	39.6%
Selling, general and administrative expense		98,308			101,401		(3,093)		-3.1%	25.8%	27.1%
Asset impairment charges		-			-		-		0.0%	0.0%	0.0%
Operating income		49,393			47,052		2,341		5.0%	13.0%	12.6%
Nonoperating income (expense), net		13			(16)		29		*	0.0%	0.0%
Interest expense		(2,513		)	(3,232)		719		-22.3%	-0.7%	-0.9%
Total other income (expense)		(2,500		)	(3,248)		748		-23.0%	-0.7%	-0.9%
Income before income taxes		46,893			43,804		3,089		7.1%	12.3%	11.7%
Income tax expense		9,369			6,085		3,284		54.0%	2.5%	1.6%
Net income		$	37,524		$	37,719	$	(195)	-0.5%	9.9%	10.1%
	Nine Months Ended November 30,									% of Sales Revenue, net
		2013			2012		$ Change		% Change	2013	2012
Sales revenue by segment, net
Housewares		$	208,471		$	192,606	$	15,865	8.2%	20.8%	20.0%
Healthcare / Home Environment		424,398			391,061		33,337		8.5%	42.2%	40.6%
Personal Care		371,764			378,554		(6,790)		-1.8%	37.0%	39.3%
Total sales revenue, net		1,004,633			962,221		42,412		4.4%	100.0%	100.0%
Cost of goods sold		613,513			575,590		37,923		6.6%	61.1%	59.8%
Gross profit		391,120			386,631		4,489		1.2%	38.9%	40.2%
Selling, general and administrative expense		278,697			277,590		1,107		0.4%	27.7%	28.8%
Asset impairment charges		12,049			-		12,049		*	1.2%	0.0%
Operating income		100,374			109,041		(8,667)		-7.9%	10.0%	11.3%
Nonoperating income (expense), net		153			38		115		*	0.0%	0.0%
Interest expense		(7,647		)	(9,674)		2,027		-21.0%	-0.8%	-1.0%
Total other income (expense)		(7,494		)	(9,636)		2,142		-22.2%	-0.7%	-1.0%
Income before income taxes		92,880			99,405		(6,525)		-6.6%	9.2%	10.3%
Income tax expense		17,647			15,246		2,401		15.7%	1.8%	1.6%
Net income		$	75,233		$	84,159	$	(8,926)	-10.6%	7.5%	8.7%

    * Calculation is not meaningful

- 22 -

Comparison of the three months ended November 30, 2013 to the three months ended November 30, 2012

Consolidated net sales revenue:

Consolidated net sales revenue for the three months ended November 30, 2013 increased $6.13 million to $380.73 million compared to $374.60 million for the same period last year, an increase of 1.6 percent.  Net sales revenue in our Housewares segment increased $6.99 million, or 10.3 percent, when compared to the same period last year.  Net sales revenue in our Healthcare / Home Environment segment increased $7.58 million, or 4.8 percent, when compared to the same period last year.  These gains were partially offset by net sales revenue declines in our Personal Care segment of  $8.44 million, or 5.7 percent, when compared to the same period last year.

Impact of acquisitions on net sales revenue:

Because we are an acquisition-oriented company, we have historically provided an analysis of our net sales revenues in terms of organic growth from our core business (business owned and operated over the same fiscal period last year) and growth from acquisitions (business that we have acquired and operated for less than twelve months during each period presented).  Net sales revenue from internally developed brands or product lines is always considered to be core business. Our last acquisition occurred on December 30, 2011. Accordingly, for the three months ended November 30, 2013, all net sales revenue growth is organic growth from our core business, as shown in the table below.

IMPACT OF ACQUISITIONS ON NET SALES REVENUE

(in thousands)

	Three Months Ended November 30,
		2013		2012
Prior year’s sales revenue, net		$	374,599	$	338,785
Components of net sales revenue change
Core business		6,131		7,738
Incremental net sales revenue from acquisitions:
PUR (three months in fiscal 2013)		-		28,076
Change in sales revenue, net		6,131		35,814
Sales revenue, net		$	380,730	$	374,599
Total net sales revenue growth		1.6%		10.6%
Core business		1.6%		2.3%
Acquisitions		-		8.3%

Impact of foreign currencies on net sales revenue:

During the three months ended November 30, 2013, we transacted approximately 16 percent of our net sales revenues in foreign currencies.  This compares to approximately 18 percent for the same period last year.  These transactions were primarily denominated in British Pounds, Euros, Mexican Pesos, Canadian Dollars, Australian Dollars, Peruvian Soles, and Venezuelan Bolivares Fuertes. For the three months ended November 30, 2013, the impact of net foreign currency exchange rate fluctuations decreased our international net sales revenue by approximately $1.60 million.  Most of the impact of these fluctuations affected sales in our Personal Care segment.

Segment net sales revenue:

Housewares Segment - Net sales revenue in the Housewares segment for the three months ended November 30, 2013 increased $6.99 million, or 10.3 percent, to $74.78 million compared with $67.79 million for the same period last year. From a product perspective, the Housewares segment’s quarterly net sales revenue growth was principally driven by volume growth in kitchen tools and gadgets, baking, cleaning, and dry food storage.  From a customer perspective, growth continues to be driven by expanded shelf space and assortments at several key retailers, continued growth in internet sales, an expansion of the wholesale club

- 23 -

business, and increased closeout activity in the third quarter of fiscal year 2014. Approximately $3.00 million of promotionally priced shipments moved into the third quarter of fiscal year 2014 based on order flow from our customers. These orders historically have shipped in the second quarter of the fiscal year. We expect the Housewares segment’s sales growth in the fourth quarter of fiscal year 2014 to be in the low to mid single digits, primarily due to the impact of certain fourth quarter fiscal year 2013 promotional programs in the wholesale club business, which will not re-occur this fiscal year.

Healthcare / Home Environment Segment - Net sales revenue in the Healthcare / Home Environment segment for the three months ended November 30, 2013 increased $7.58 million, or 4.8 percent, to $165.75 million compared with $158.17 million for the same period last year. Slight declines in volume and higher promotional allowances were offset by better selling price mix.  The air purification product category contributed to net sales revenue growth for the quarter, particularly a new line of quiet air cleaners featuring easy to clean permanent air filters.  Sales gains in higher-end thermometry and associated consumables, particularly in the professional channels, also contributed to net sales revenue growth.  The segment also experienced net sales revenue increases in water filtration and humidification products, largely as a result of new products and new distribution coupled with increased advertising and promotional activity.

Personal Care Segment - Net sales revenue in the Personal Care segment for the three months ended November 30, 2013 decreased $8.44 million, or 5.7 percent, to $140.20 million compared with $148.64 million for the same period last year.  The retail environment for this segment remains difficult and highly promotional. The decrease in net sales revenue was spread across all major product categories driven by volume declines, a shift in mix to lower priced goods and increased promotional allowances.  The domestic retail appliance product category continues to be negatively impacted by lost shelf space at a major retailer.  The grooming, skin care and hair care solutions product category continued to confront significant competitive product launches and associated promotional spending in hair care, inventory rationalization at large retailers, and changing customer order replenishment practices leading to elevated out-of-stock positions on retail shelves.

Consolidated gross profit margin:

Consolidated gross profit margin as a percentage of net sales revenue for the three months ended November 30, 2013 decreased 0.8 percentage points to 38.8 percent compared to 39.6 percent for the same period last year.  Our consolidated gross profit margin continued to be unfavorably impacted by increased promotional program costs, the effect of foreign currency exchange rates on net sales revenue and the continuing trend of general product cost increases across all segments.  In addition, the growth of the Healthcare / Home Environment segment’s net sales revenue has a dilutive impact on gross margins because its overall gross margins are lower than our other two segments.

Our product sourcing mix is heavily dependent on imports from China. China’s currency is no longer pegged solely to the U.S. dollar. As a result, we believe China’s currency will continue to appreciate against the U.S. Dollar in the short-to-intermediate-term, resulting in increased product costs over time.  Furthermore, if increases in the underlying costs of labor and commodities in China occur, we expect that they would also result in future increases in our product costs.

Selling, general and administrative expense:

SG&A decreased 1.3 percentage points, to 25.8 percent of net sales revenue for the three months ended November 30, 2013, compared to 27.1 percent for the same period last year.  The decrease in SG&A as a percentage of net sales revenue is primarily due to the combined effects of lower media advertising costs and the favorable comparative impact arising from a product packaging litigation expense recorded during the same quarter last year.  These expense reductions were partially offset by higher incentive compensation costs.

- 24 -

Operating income by segment:

The following tables set forth, for the periods indicated, our operating income by segment as a year-over-year percentage change and as a percentage of net sales revenue for each segment and the Company overall:

OPERATING INCOME BY SEGMENT

(dollars in thousands)

	Three Months Ended November 30,									% of Sales Revenue, net
		2013		2012		$ Change			% Change	2013		2012
Housewares		$	15,278	$	13,927	$	1,351		9.7%	20.4	%	20.5	%
Healthcare / Home Environment		10,665		11,323		(658		)	-5.8%	6.4	%	7.2	%
Personal Care		23,450		21,802		1,648			7.6%	16.7	%	14.7	%
Total operating income		$	49,393	$	47,052	$	2,341		5.0%	13.0	%	12.6	%

We compute operating income for each segment based on net sales revenue, less cost of goods sold and SG&A associated with the segment.  The SG&A used to compute each segment’s operating income is directly associated with the segment, plus overhead expenses that are allocable to the segment. We make allocations of overhead between operating segments using a number of relevant allocation criteria, depending on the nature of the expense, the most significant of which are relative revenues, estimates of relative labor expenditures, headcount, and facility square footage.  We do not allocate nonoperating income and expense, interest or income taxes to operating segments.

Housewares Segment - The Housewares segment’s operating income for the three months ended November 30, 2013 increased $1.35 million, or 9.7 percent, compared to the same period last year. The increase in operating income for the period reported is principally due to an increase in net sales revenue and improved overall operating leverage, partially offset by the gross margin impact of higher closeout and wholesale club sales, and higher product costs.

Healthcare / Home Environment Segment - The Healthcare / Home Environment segment’s operating income for the three months ended November 30, 2013 decreased $0.66 million, or 5.8 percent, compared to the same period last year. The decrease in operating income was principally due to higher cooperative advertising and promotional allowances, certain incentive compensation costs exclusive to the segment, higher product costs and higher allocations of overhead.  These factors were partially offset by the combined effects of lower media advertising costs and the favorable comparative impact arising from a product packaging litigation expense recorded during the same quarter last year.

Personal Care Segment - The Personal Care segment’s operating income for the three months ended November 30, 2013 increased $1.65 million, or 7.6 percent, compared to the same period last year. The increase in operating income was principally due to lower media and cooperative advertising costs and lower outbound freight costs, partially offset by the unfavorable impact of foreign currency exchange rate fluctuations.

Interest expense:

Interest expense for the three months ended November 30, 2013 was $2.51 million compared to $3.23 million for the same period last year.  Interest expense was lower when compared to the same period last year principally due to lower levels of debt outstanding.

Income tax expense:

Income tax expense for the three months ended November 30, 2013 was $9.37 million, or 20.0 percent of income before taxes compared to $6.09 million, or 13.9 percent of income before taxes for the same period last year. The year-over-year comparison of our effective tax rate for the quarter was impacted by discrete items that were a benefit to tax expense in the third quarter of the prior fiscal year, and shifts in the mix of taxable income between our various tax jurisdictions.  We continue to expect our effective tax rate for the full fiscal year 2014 to range between 17.0 and 19.0 percent.

- 25 -

Net income:

Net income for the three months ended November 30, 2013 was essentially flat when compared to the same period last year.  An increase in operating income of $2.34 million and a decrease in interest expense of $0.72 million were offset by an increase in income taxes of $3.28 million.

Comparison of the nine months ended November 30, 2013 to the nine months ended November 30, 2012

Consolidated net sales revenue:

Consolidated net sales revenue for the nine months ended November 30, 2013 increased $42.41 million to $1,004.63 million compared to $962.22 million for the same period last year, an increase of 4.4 percent.  Net sales revenue in our Housewares segment increased $15.87 million, or 8.2 percent, when compared to the same period last year.  Net sales revenue in our Healthcare / Home Environment segment increased $33.34 million, or 8.5 percent, when compared to the same period last year.  Net sales revenue in our Personal Care segment decreased $6.79 million, or 1.8 percent, when compared to the same period last year.

Impact of acquisitions on net sales revenue:

Because we are an acquisition-oriented company, we have historically provided an analysis of our net sales revenues in terms of organic growth from our core business (business owned and operated over the same fiscal period last year) and growth from acquisitions (business that we have acquired and operated for less than twelve months during each period presented).  Net sales revenue from internally developed brands or product lines is always considered to be core business. Our last acquisition occurred on December 30, 2011. Accordingly, for the nine months ended November 30, 2013, all net sales revenue growth is organic growth from our core business, as shown in the table below.

IMPACT OF ACQUISITIONS ON NET SALES REVENUE

(in thousands)

	Nine Months Ended November 30,
	2013		2012
Prior year’s sales revenue, net	$	962,221	$	887,672
Components of net sales revenue change
Core business	42,412		(4,070		)
Incremental net sales revenue from acquisitions:
PUR (nine months in fiscal 2013)	-		78,619
Change in sales revenue, net	42,412		74,549
Sales revenue, net	$	1,004,633	$	962,221
Total net sales revenue growth	4.4%		8.4%
Core business	4.4%		-0.5%
Acquisitions	-		8.9%

Impact of foreign currencies on net sales revenue:

During the nine months ended November 30, 2013, we transacted approximately 15 percent of our net sales revenues in foreign currencies.  This compares to 17 percent for the same period last year.  These transactions were primarily denominated in British Pounds, Euros, Mexican Pesos, Canadian Dollars, Australian Dollars, Peruvian Soles, and Venezuelan Bolivares Fuertes.  For the nine months ended November 30, 2013, the impact of net foreign currency exchange rate fluctuations decreased our international net sales revenue by approximately $3.70 million.  Most of the impact of these fluctuations affected sales in our Personal Care segment.

- 26 -

Segment net sales revenue:

Housewares Segment - Net sales revenue in the Housewares segment for the nine months ended November 30, 2013 increased $15.87 million, or 8.2 percent, to $208.47 million compared with $192.61 million for the same period last year.  From a product perspective, the Housewares segment’s net sales revenue growth was principally driven by volume growth in kitchen tools and gadgets, baking, cleaning, and dry food storage. The segment also continues to expand the market penetration of our line of infant and toddler care products.  From a customer perspective, growth was driven by expanded shelf space and assortments at several key retailers, continued growth in internet sales, an expansion of the wholesale club business, and new customer distribution in the current fiscal year.

Healthcare / Home Environment Segment - Net sales revenue in the Healthcare / Home Environment segment for the nine months ended November 30, 2013 increased $33.34 million, or 8.5 percent, to $424.40 million compared with $391.06 million for the same period last year.  From a product perspective, growth in thermometry, water filtration, air purification and humidification products provided net sales revenue gains, which were partially offset by lost distribution in hot/cold therapy and weak insect control sales resulting from a cool, dry spring in North America that affected most participants in the market segment.  From a customer perspective, the segment has seen growth with customers in the mass retail, internet and home improvement channels.

Personal Care Segment - Net sales revenue in the Personal Care segment for the nine months ended November 30, 2013 decreased $6.79 million, or 1.8 percent, to $371.76 million compared with $378.55 million for the same period last year.  The segment has been contending with a difficult retail environment throughout the fiscal year.  Declines in our domestic retail appliance and grooming, skin care and hair care product categories were partially offset by a new European product distribution arrangement specific to the current fiscal year, year-over-year gains in domestic professional appliances and international growth.  The domestic retail appliance product category has been negatively impacted by lost shelf space at a major retailer and higher promotional discounts, which has been partially offset by increased distribution elsewhere.  The grooming, skin care and hair care solutions product category continues to confront significant competitive product launches and associated promotional spending in hair care, inventory rationalization at large retailers, and changing customer order replenishment practices leading to elevated out-of-stock positions on retail shelves.

Consolidated gross profit margin:

Consolidated gross profit margin as a percentage of net sales revenue for the nine months ended November 30, 2013 decreased 1.3 percentage points to 38.9 percent compared to 40.2 percent for the same period last year. Our consolidated gross profit margin continues to be unfavorably impacted by increased promotional program costs, the effect of foreign currency exchange rate fluctuations on net sales revenue and the continuing trend of general product cost increases across all segments.  In addition, the growth of the Healthcare / Home Environment segment’s net sales revenue has a dilutive impact on gross margins because its overall gross margins are lower than our other two segments.

Our product sourcing mix is heavily dependent on imports from China. China’s currency is no longer pegged solely to the U.S. dollar. As a result, we believe China’s currency will continue to appreciate against the U.S. Dollar in the short-to-intermediate-term, resulting in increased product costs over time.  Furthermore, if increases in the underlying costs of labor and commodities in China occur, we expect that they would also result in future increases in our product costs.

- 27 -

Selling, general and administrative expense:

SG&A decreased 1.1 percentage points, to 27.7 percent of net sales revenue for the nine months ended November 30, 2013, compared to 28.8 percent for the same period last year.  The year-over-year decrease in SG&A as a percentage of net sales revenue is primarily due to: lower outbound freight and distribution costs, reduced media advertising costs and the favorable comparative impact arising from a product packaging litigation expense recorded during the third fiscal quarter last year.   These year-over-year expense reductions were partially offset by higher incentive compensation costs.

Asset impairment charges:

We performed our annual evaluation of goodwill and indefinite-lived intangible assets for impairment during the first quarter of fiscal year 2014. As a result of our testing of indefinite-lived trademarks and licenses, we recorded a non-cash asset impairment charge of $12.05 million ($12.03 million after tax) during the fiscal quarter ended May 31, 2013.  The charge was related to certain trademarks in our Personal Care segment, which were written down to their estimated fair value as a result of lower revenue outlooks due to competitive factors.  The fair values were determined on the basis of future discounted cash flows using the relief from royalty valuation method.

Operating income by segment:

The following tables set forth, for the periods indicated, our operating income by segment as a year-over-year percentage change and as a percentage of net sales revenue for each segment and the Company overall:

OPERATING INCOME BY SEGMENT

(dollars in thousands)

	Nine Months Ended November 30,									% of Sales Revenue, net
		2013		2012		$ Change			% Change	2013		2012
Housewares		$	41,506	$	37,282	$	4,224		11.3%	19.9	%	19.4	%
Healthcare / Home Environment		22,175		26,197		(4,022		)	-15.4%	5.2	%	6.7	%
Personal Care		36,693		45,562		(8,869		)	-19.5%	9.9	%	12.0	%
Total operating income		$	100,374	$	109,041	$	(8,667	)	-7.9%	10.0	%	11.3	%

See page 25 for an explanation of how we compute operating income for each segment.

Housewares Segment – The Housewares segment’s operating income for the nine months ended November 30, 2013 increased $4.22 million, or 11.3 percent, compared to the same period last year. The increase in operating income for the period reported is principally due to an increase in net sales revenue, improved overall operating leverage, and lower domestic distribution costs.  These favorable factors have been partially offset by higher product costs.

Healthcare / Home Environment Segment – The Healthcare / Home Environment segment’s operating income for the nine months ended November 30, 2013 decreased $4.02 million, or 15.4 percent, compared to the same period last year. The decrease in operating income was principally due to certain incentive compensation costs exclusive to the segment, higher product costs and higher allocations of overhead.  These factors were partially offset by the combined effects of lower media advertising costs and the favorable comparative impact arising from a product packaging litigation expense recorded during the third fiscal quarter last year.

Personal Care Segment – The Personal Care segment’s operating income for the nine months ended November 30, 2013 decreased $8.87 million, or 19.5 percent, compared to the same period last year. The decrease in operating income was principally due to a decline in sales, the impact of higher promotional allowances and cooperative advertising,  higher product costs, the unfavorable impact of foreign currency exchange rate fluctuations, increased incentive compensation cost allocations, and a non-cash asset impairment charge (as further discussed above under “Asset impairment charges”).  These unfavorable factors were partially offset by lower media advertising costs.

- 28 -

Interest expense:

Interest expense for the nine months ended November 30, 2013 was $7.65 million compared to $9.67 million for the same period last year.   Interest expense was lower when compared to the same period last year principally due to lower levels of debt outstanding.

Income tax expense:

Income tax expense for the nine months ended November 30, 2013 was $17.65 million, or 19.0 percent of income before taxes compared to $15.25 million, or 15.3 percent of income before taxes, for the same period last year.  The year-over-year comparison of our effective tax rate for the fiscal year-to-date was impacted by discrete items that were a benefit to tax expense in the third quarter of the prior fiscal year, and shifts in the mix of taxable income between our various tax jurisdictions. The fiscal year-to-date effective tax rate was also impacted by asset impairment charges of $12.05 million recorded during the first quarter of fiscal year 2014, for which the related tax benefit was only $0.02 million.  We continue to expect our effective tax rate for the full fiscal year 2014 to range between 17.0 and 19.0 percent.

Net income:

Net income for the nine months ended November 30, 2013 decreased by $8.93 million compared to the same period last year.  The decline is primarily due to the unfavorable impact of asset impairment charges of $12.03 million, net of tax, recorded during the first quarter of fiscal 2014 as a result of our annual evaluation of goodwill and indefinite-lived intangible assets, a higher effective tax rate year-over-year, as well as the other factors described above.

Income without impairments increased $3.11 million to $87.27 million for the nine months ended November 30, 2013, compared to $84.16 million for the same period last year.  The increase was due to organic net sales revenue growth of 4.4 percent, a 1.1 percentage point decline in SG&A and lower interest expense, partially offset by higher product costs and income taxes year-over-year.   The following table presents the comparative impact of the asset impairment charges on our net income, and basic and diluted earnings per share for the nine months ended November 30, 2013 and 2012:

IMPACT OF ASSET IMPAIRMENT CHARGES ON NET INCOME AND EARNINGS PER SHARE

(dollars in thousands, except per share data)

	Nine Months Ended November 30,				Basic Earnings per Share				Diluted Earnings per Share
	2013		2012		2013		2012		2013		2012
Net income, as reported	$	75,233	$	84,159	$	2.35	$	2.65	$	2.33	$	2.64
Asset impairment charges, net of tax	12,034		-		0.38		-		0.37		-
Income without impairments	$	87,267	$	84,159	$	2.73	$	2.65	$	2.70	$	2.64

The table shown above entitled “Impact of Asset Impairment Charges on Net Income and Earnings per Share” reports income and earnings per share, which exclude asset impairment charges. Income without impairments and earnings per share without impairments, as discussed in the preceding table, may be considered non-GAAP financial information as set forth in SEC Regulation G, Rule 100. The preceding table reconciles these measures to their corresponding GAAP-based measures presented in our consolidated condensed statements of income.  We believe that income without impairments and earnings per share without impairments measures provide useful information to management and investors regarding financial and business trends relating to its financial condition and results of operations. We believe that income without impairments and earnings per share without impairments measures, in combination with the Company’s financial results calculated in accordance with GAAP, provide investors with additional perspective regarding the impact of asset impairment charges on net income and earnings per share. We also believe that these non-GAAP measures facilitate a more direct comparison of the Company’s performance with its competitors.  We further believe that including the

- 29 -

excluded asset impairment charges would not accurately reflect the underlying performance of the Company’s continuing operations for the period in which the impairments are incurred, even though asset impairment charges may be incurred and reflected in the Company’s GAAP financial results in the foreseeable future. The material limitation associated with the use of the non-GAAP financial measures is that the non-GAAP measures do not reflect the full economic impact of the Company’s activities.  The Company’s income without impairments and earnings per share without impairments measures are not prepared in accordance with GAAP, are not an alternative to GAAP financial information and may be calculated differently than non-GAAP financial information disclosed by other  companies.  Accordingly, undue reliance should not be placed on non-GAAP information.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

Selected measures of our liquidity and capital resources for the nine months ended November 30, 2013 and 2012 are shown below:

SELECTED MEASURES OF OUR LIQUIDITY AND CAPITAL UTILIZATION

	Nine Months Ended November 30,
	2013		2012
Accounts Receivable Turnover (Days) (1)	65.5		62.7
Inventory Turnover (Times) (1)	2.7		2.7
Working Capital (in thousands)	$	278,837	$	217,033
Current Ratio	1.8 : 1		1.6 : 1
Ending Debt to Ending Equity Ratio (2)	21.3%		35.8%
Return on Average Equity (1)(3)	11.3%		13.7%

(1)Accounts receivable turnover, inventory turnover and return on average equity computations use 12-month trailing sales, cost of sales or net income components as required by the particular measure.   The current and four prior quarters’ ending balances of accounts receivable, inventory, and equity are used for the purposes of computing the average balance component as required by the particular measure.

(2)Debt is defined as all debt outstanding at the balance sheet date. This includes the sum of the following lines on our consolidated condensed balance sheets: “Revolving line of credit,” “Long-term debt, current maturities” and “Long-term debt, excluding current maturities.”

(3)For the nine months ended November 30, 2013, a non-cash impairment charge of $12.05 million ($12.03 million after tax) had an unfavorable impact of 1.2 percentage points on return on average equity.

Operating activities:

Operating activities provided $91.11 million of cash during the first nine months of fiscal year 2014, compared to $24.33 million of cash provided during the same period in fiscal year 2013.  The increase in operating cash flow was primarily due to the timing of fluctuations in working capital components, particularly year-over-year changes in inventory activity, when compared to the same period last year.

Accounts receivable increased $59.98 million to $279.70 million as of November 30, 2013, compared to $219.72 million at the end of fiscal year 2013 due to seasonality in our business.  Accounts receivable turnover increased to 65.5 days at November 30, 2013 compared to 62.7 days at November 30, 2012.  This calculation is based on a rolling five quarter accounts receivable balance.

Inventories increased $9.02 million to $289.89 million as of November 30, 2013, compared to $280.87 million at the end of fiscal year 2013. The year-to-date inventory increase is primarily due to normal seasonal fluctuations.  Inventories at November 30, 2013 decreased $16.40 million compared to the November 30, 2012 balance of $306.29 million.  Inventory turnover was 2.7 times at November 30, 2013 and 2012.

- 30 -

Working capital was $278.84 million at November 30, 2013, compared to $217.03 million at November 30, 2012.  The increase in working capital over the last twelve months is primarily caused by the repayment of our debt.  Cash from operations was used to pay down $138.50 million of short-term debt and increased accounts receivable.  This was partially offset by the reclassification of $20.00 million and $75.00 million of long-term debt scheduled to mature in January 2014 and June 2014, respectively, as current liabilities.  As a result, our current ratio increased to 1.8:1 at November 30, 2013, compared to 1.6:1 at November 30, 2012.

Investing activities:

Investing activities used $38.56 million of cash during the nine months ended November 30, 2013. Highlights of those activities follow:

·We spent $29.92 million on building and improvements, primarily in connection with the construction of our new distribution facility in Olive Branch, Mississippi; and

·We spent $7.18 million on information technology infrastructure and other furniture and equipment,  $1.19 million on tools, molds and other capital asset additions and $0.27 million on the development of new patents.

Financing activities:

Financing activities used $36.62 million of cash during the nine months ended November 30, 2013.  Highlights of those activities follow:

·We had draws of $107.30 million against our revolving credit agreement;

·We repaid $184.40 million drawn against our revolving credit agreement;

·We had draws of $35.51 million against new debt to finance the construction of our new distribution facility in Olive Branch, Mississippi;

·We incurred $0.13 million in debt acquisition costs in connection with new long-term debt;

·Employees and certain members of our Board of Directors exercised options to purchase 170,859 shares of common stock, and employees purchased 20,028 shares of common stock through our Employee Stock Purchase Plan. These programs provided a combined $5.02 million of cash, including tax benefits;

·We paid $0.48 million in tax obligations in connection with the vesting of certain restricted stock grants to our Chief Executive Officer and members of our Board of Directors;

·We repurchased and retired 33,862 shares of common stock at an average price of $38.71 per share for a  total purchase price of $1.31 million; and

·Share-based compensation expenses provided $1.88 million in current tax benefits.

Revolving Line of Credit Agreement and Other Debt Agreements:

We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., that provides for anunsecured total revolving commitment of up to $250.00 million. The commitment under the Credit Agreement terminates on December 30, 2015. With each borrowing, we can elect the interest rate method based on our funding needs at the time. Borrowings under the Credit Agreement accrue interest at a base rate plus a margin of 0.00 to 1.125 percent per annum based on the Leverage Ratio (as defined in the Credit Agreement) at the time of borrowing. The base rate is equal to the highest of the Federal Funds Rate (as defined in the Credit Agreement) plus 0.50 percent, Bank of America’s prime rate or the one-month LIBOR rate plus 1.00 percent. Alternatively, if

- 31 -

we elect, borrowings accrue interest based on the respective one-, two-, three-, or six-month LIBOR rate plus a margin of 1.00 to 2.125 percent per annum based upon the Leverage Ratio at the time of the borrowing. We also incur loan commitment fees and letter of credit fees under the Credit Agreement. Outstanding letters of credit reduce the borrowing availability under the Credit Agreement on a dollar-for-dollar basis. As of November 30, 2013, the outstanding revolving loan principal balance was $4.90 million and there were $0.28 million of open letters of credit outstanding against the Credit Agreement. For the three- and nine-months ended November 30, 2013, borrowings under the Credit Agreement incurred interest charges at rates ranging from 1.17 to 3.25 percent and 1.17 to 3.63 percent, respectively. For both the three- and nine-month periods ended November 30, 2012, borrowings under the Credit Agreement incurred interest charges at rates ranging from 1.59 to 4.00 percent. As of November 30, 2013, the amount available for borrowings under the Credit Agreement was $244.82 million.

In addition to the Credit Agreement, at November 30, 2013, we had an aggregate principal balance of $175.00 million of Senior Notes with varying maturities due between January 2014 and January 2018 and interest rates ranging from 3.90 to 6.01 percent. $75.00 million of the debt can be prepaid without penalty and $100.00 million of the debt is subject to a “make-whole” premium if repaid before maturity.

In March 2013, Kaz USA, Inc. (“Kaz USA”), a wholly owned subsidiary of the Company, entered into a Loan Agreement, dated as of March 1, 2013, with the Mississippi Business Finance Corporation (the “MBFC”) in connection with the issuance by the MBFC of up to $38.00 million of taxable industrial development revenue bonds (the “Bonds”). The Bonds are issued under a Trust Indenture (the “IRB Indenture”), between the MBFC and Deutsche Bank National Trust Company, as trustee. Interim draws, accumulating up to a $38.00 million aggregate maximum, may be made through March 20, 2014. The Bonds and the related loan to Kaz USA (the “MBFC Loan”) will bear interest at a variable rate as elected by Kaz USA equal to either (a) a “Base Rate” plus a margin of 0.00 to 1.125 percent depending upon the leverage ratio at the time of the borrowing or (b) the respective one-, two-, three-, or six-month LIBOR rate plus 1.00 to 2.125 percent, depending upon the leverage ratio at the time of the borrowing. The Base Rate is equal to the highest of (i) the federal funds rate for the day, plus 0.50 percent, (ii) the prime rate of Bank of America, N.A., or (iii) the respective one-, two-, three-, or six-month LIBOR rate plus 1.00 percent. The proceeds of the MBFC Loan have been used by Kaz USA to finance the purchase of land, construction of a distribution facility and the acquisition and installation of equipment, machinery and related assets located in Olive Branch, Mississippi.

Assuming the $38.00 million aggregate maximum is borrowed, outstanding principal of the MBFC Loan will be payable as follows: $1.90 million on March 1 in each of 2014, 2015, 2018, 2019, 2020, 2021, and 2022; $3.80 million on March 1, 2016; $5.70 million on March 1, 2017; and $15.20 million on March 1, 2023. Any remaining outstanding principal and interest is due upon the maturity of the MBFC Loan on March 1, 2023.  The MBFC Loan may be prepaid in whole or part without penalty any time after March 20, 2014. Additionally, Bank of America, N.A., the purchaser of the Bonds, may elect for the MBFC Loan to be prepaid in full on March 1, 2018.  Following March 1, 2018, Bank of America, N.A. may elect for the MBFC Loan to be prepaid on March 1 of each subsequent year prior to maturity upon at least 90 days notice. In lieu of any prepayment, the Bonds may be purchased by a transferee, as permitted under the IRB Indenture.

All of our debt is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries. Our debt agreements require the maintenance of certain financial covenants, including maximum leverage ratios, minimum interest coverage ratios and minimum consolidated net worth levels (as each of these terms are defined in the various agreements). Our debt agreements also contain other customary covenants, including, among other things, covenants restricting or limiting the Company, except under certain conditions set forth therein, from (1) incurring debt, (2) incurring liens on its properties, (3) making certain types of investments, (4) selling certain assets or making other fundamental changes relating to mergers and consolidations, and (5) repurchasing shares of our common stock and paying dividends. Our debt agreements also contain customary events of default, including failure to pay principal or interest when due, among others. Our debt agreements are cross-defaulted to each other. Upon an event of default under our debt agreements, the holders or lenders may, among other things, accelerate the maturity of any amounts outstanding under our debt. Under the terms of our Credit Agreement, the commitments of the lenders to make loans to us are several and not joint. Accordingly, if any lender fails to make loans to us, our available liquidity could be reduced by an amount up to the aggregate amount of such lender’s commitments under the revolving credit facility.

- 32 -

The table below provides the formulas for certain key financial covenants as defined in our various debt agreements:

Applicable Financial Covenant	Credit Agreement and MBFC Loan	$75 Million Floating Rate Senior Notes	$100 Million 3.90% Fixed Rate Senior Notes
Minimum Consolidated Net Worth	$530 Million  + 100% of Increase in
	Equity Due to Sale of Equity Interests	$260 Million	$500 Million
	After August 31, 2010	+	+
	+	25% of Fiscal Quarter Net Earnings	25% of Fiscal Quarter Net Earnings
	40% of Fiscal Quarter Net Earnings	After February 29, 2004 (1)	After August 31, 2010 (1)
	After August 31, 2010 (1)
Interest Coverage Ratio	EBIT (2)	None	EBIT (2)
	÷		÷
	Interest Expense (2)		Interest Expense (2)
	Minimum Required:  3.00 to 1.00		Minimum Required:  2.50 to 1.00
Maximum Leverage Ratio	Total Current and Long Term Debt (3)	Total Current and Long Term Debt (3)	Total Current and Long Term Debt (3)
	÷	÷	÷
	[EBITDA (2) + Pro Forma Effect of	Total Capitalization (3)	[ EBITDA (2) + Pro Forma Effect of Acquisitions ]
	Acquisitions]
	Maximum Allowed:  3:00 to 1:00	Maximum Allowed:  55%	Maximum Allowed:  3:25 to 1:00

Key Definitions:

EBIT:	Earnings Before Non-Cash Charges, Interest Expense and Taxes
EBITDA:	EBIT  +  Depreciation and Amortization Expense  +  Share Based Compensation
Total Capitalization:	Total Current and Long Term Debt  +  Total Equity
Pro Forma Effect of Acquisitions:	For any acquisition, pre-acquisition EBITDA of the acquired business is included so that the EBITDA of the acquired business included in the computation equals its twelve month trailing total.

Notes:

(1) Excluding any fiscal quarter net losses.

(2) Computed using totals for the latest reported four consecutive fiscal quarters.

(3) Computed using the ending balances as of the latest reported fiscal quarter.

- 33 -

Contractual obligations and commercial commitments:

Our contractual obligations and commercial commitments at November 30, 2013, were:

PAYMENTS DUE BY PERIOD - TWELVE MONTHS ENDED NOVEMBER 30:

(in thousands)

			2014		2015		2016		2017		2018		After
	Total		1 year		2 years		3 years		4 years		5 years		5 years
Term debt - fixed rate	$	100,000	$	20,000	$	20,000	$	20,000	$	20,000	$	20,000	$	-
Term debt - floating rate (1)	110,509		76,900		1,900		3,800		5,700		1,900		20,309
Long-term incentive plan payouts	10,372		3,811		3,350		1,978		1,233		-		-
Interest on fixed rate debt	8,255		3,211		2,431		1,651		871		91		-
Interest on floating rate debt (1)	5,053		3,039		375		336		276		242		785
Open purchase orders	195,614		195,614		-		-		-		-		-
Long-term purchase commitments	3,029		606		606		606		606		605		-
Minimum royalty payments	80,059		12,733		12,758		12,757		9,690		9,464		22,657
Advertising and promotional	52,577		8,016		5,134		5,237		5,342		5,449		23,399
Operating leases	11,356		4,016		2,783		1,711		1,342		1,199		305
Capital spending commitments	636		636		-		-		-		-		-
Total contractual obligations (2)	$	577,460	$	328,582	$	49,337	$	48,076	$	45,060	$	38,950	$	67,455

(1)The Company uses an interest rate hedge agreement (the “swap”) in conjunction with its unsecured, floating interest rate, $75.00 million Senior Notes due June 2014. The swap hedges the variable LIBOR rates used to reset the floating rates on these Senior Notes. The swap effectively fixes the interest rates on the Senior Notes due June 2014 at 6.01 percent.

(2)In addition to the contractual obligations and commercial commitments in the table above, as of November 30, 2013, we have recorded a provision for our uncertain tax positions of $15.52 million. We are unable to reliably estimate the timing of future payments, if any, related to uncertain tax positions.  Therefore, we have excluded these tax liabilities from the table above.

During fiscal year 2012, we entered into certain employment and incentive compensation agreements with Gerald Rubin, our Chief Executive Officer and President (the “CEO”).  The base and incentive compensation provisions of these agreements remain effective for fiscal years 2014 and 2015. Substantially all of the CEO’s compensation pursuant to these agreements is performance-based and contingent upon our achievement of specified performance goals. The performance-based compensation is made up of the following three components:

·Restricted Stock Units - The CEO received a grant of 700,000 performance-based restricted stock units (“Performance RSUs”), which may be earned in tranches based on the Company’s achievement of specified performance goals for fiscal years ending 2013, 2014 and 2015. The CEO earned 100,000 of the performance-based RSUs for the fiscal year ended February 28, 2013.  All earned Performance RSUs are subject to additional time-based vesting requirements. Up to 200,000 Performance RSUs may be earned based on the Company’s achievement of the specified performance goals for fiscal year 2014. With respect to fiscal year 2015, up to 700,000 Performance RSUs (less the number of Performance RSUs previously earned) may be earned based on the Company’s achievement of either the specified performance goal for fiscal year 2015 or the three year average performance goal for the three fiscal years 2013 through 2015. A portion of the Performance RSUs earned in fiscal year 2013 and any Performance RSUs earned in fiscal year 2014 are subject to annual vesting requirements through fiscal year 2015. The Performance RSUs had a fair value at the date of grant of $32.88 per share for a grant date fair value of $23.02 million. Compensation expense associated with Performance RSUs is equal to the market value of our common stock on the date of the grant multiplied by the number of Performance RSUs vesting during any given period. Expense for each tranche must be estimated until earned, subject to a probability assessment of achieving the performance criteria specified for the tranche. We are recording the expense for each tranche over the related vesting and service periods in SG&A.

- 34 -

·Annual Bonus - The CEO is also eligible to receive an annual bonus of up to $25.00 million in cash and stock, subject to the achievement of specified performance goals. Any such bonus that is earned and payable will be paid two-thirds in the form of cash or cash equivalents up to a maximum of $10.00 million. The remainder will be paid in the form of restricted stock. Any restricted stock granted will vest, with respect to annual bonuses for fiscal years 2013 and 2014, on February 28, 2015, and with respect to annual bonus for fiscal year 2015, on the date the Compensation Committee of the Company’s Board of Directors certifies that the performance goals have been achieved.

·Life Insurance Bonuses - Two split-dollar life insurance policies and the obligation to pay the associated premiums remain to be transferred to the CEO through February 28, 2015 subject to the satisfaction of certain service and performance conditions. The amount of the value of the transfer of each of the two split-dollar life insurance policies (based on cash surrender values) is capped at $4.00 and $7.00 million, respectively.

The CEO’s unvested Performance RSU’s earned in fiscal year 2013 will generate $1.10 million of performance-based compensation expense in both fiscal years 2014 and 2015.  The CEO’s restricted stock bonus earned in fiscal year 2013 will generate $1.89 million of performance-based compensation expense in both fiscal years 2014 and 2015.

We currently expect Mr. Rubin to achieve certain performance targets for fiscal 2014 and the accompanying consolidated condensed financial statements include estimated accruals for his Performance RSU’s, annual bonus and life insurance bonus under the various applicable agreements.  To the extent of his achievement of performance targets for fiscal 2014 and 2015 (in full or in part), the resulting incentive compensation expense could have a significant impact upon SG&A and net income in those years.  The expense we will actually record in fiscal years 2014 and 2015 will depend on the actual operating income achieved each year, as well as other factors that are components to the relevant performance targets underlying the compensation.  Unanticipated events and circumstances may occur that could impact the timing of the accrual of the expense and the amount of incentive compensation expense recorded.  For information concerning pro forma performance compensation expense, see “Management Discussion and Analysis – Financial Condition, Liquidity and Capital Resources” in our annual report on Form 10-K for the year ended February 28, 2013.  The timing and actual amount expensed as compensation during fiscal years 2014 and 2015 will vary from pro forma amounts described in the Form 10-K, and the variations might be material. Accordingly, the pro forma amounts in the Form 10-K are for illustrative purposes only.

Off-balance sheet arrangements:

We have no existing activities involving special purpose entities or off-balance sheet financing.

Current and future capital needs:

Based on our current financial condition and current operations, we believe that cash flows from operations and available financing sources will continue to provide sufficient capital resources to fund our foreseeable short- and long-term liquidity requirements.  These requirements include $20.00 million of annual principal payments on the $100.00 million Senior Notes, beginning in January 2014,  principal payments on the $38.00 million MBFC Loan beginning in March 2014, and the repayment in full of $75.00 million of Senior Notes in June 2014. We expect our remaining capital needs to stem primarily from the need to purchase sufficient levels of inventory and to carry normal levels of accounts receivable on our balance sheet.  In addition, we continue to evaluate acquisition opportunities on a regular basis and may augment our internal growth with acquisitions of complementary businesses or product lines. We may finance acquisition activity with available cash, the issuance of common stock, additional debt, or other sources of financing, depending upon the size and nature of any such transaction and the status of the capital markets at the time of such acquisition.

- 35 -

In addition to repurchases of shares associated with the net settlement of employee stock options, the Company may elect to repurchase additional common stock from time to time based upon its assessment of its liquidity position and market conditions at the time, and subject to limitations contained in its debt agreements.  For additional information, see Part II, Item 2. “Unregistered Sales of Equity Securities and Use of Proceeds” in this report.

CRITICAL ACCOUNTING POLICIES

The SEC defines critical accounting policies as those that are both most important to the portrayal of a company’s financial condition and results, and require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. For a discussion of our critical accounting policies, see Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, under the heading “Critical Accounting Policies” in our annual report on Form 10-K for the year ended February 28, 2013. There have been no material changes to the Company’s critical accounting policies from the information provided in our annual report on Form 10-K.

NEW ACCOUNTING PRONOUNCEMENTS

See Note 2 – “New Accounting Pronouncements,” to the accompanying consolidated condensed financial statements of this report, for a discussion of the status and potential impact of new accounting pronouncements.

- 36 -

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Changes in currency exchange rates and interest rates are our primary financial market risks.

Foreign Currency Risk:

Our functional currency is the U.S. Dollar. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”).  Such transactions include sales, certain inventory purchases and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies.  During the three- and nine-month periods ended November 30, 2013, approximately 16 and 15 percent, respectively, of our net sales revenue was in foreign currencies.  During the three- and nine-month periods ended November 30, 2012, approximately 18 and 17 percent, respectively, of our net sales revenue was in foreign currencies.  These sales were primarily denominated in British Pounds, Euros, Mexican Pesos, Canadian Dollars, Australian Dollars, Peruvian Soles, and Venezuelan Bolivares Fuertes. We make most of our inventory purchases from the Far East and use the U.S. Dollar for such purchases.  In our consolidated condensed statements of income, exchange gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets, and deferred tax liabilities, are recognized in their respective income tax lines, and all other foreign currency exchange gains and losses from remeasurement are recognized in SG&A.

A significant portion of the products we sell are purchased from third-party manufacturers in China. During the first nine months of fiscal year 2014, the Chinese Renminbi appreciated against the U.S. Dollar approximately 3 percent.  During fiscal year 2013, the Chinese Renminbi remained relatively flat against the U.S. Dollar. During fiscal years 2012 and 2011, the Chinese Renminbi appreciated against the U.S. Dollar approximately 4 percent each period. To the extent the Chinese Renminbi appreciates with respect to the U.S. Dollar in the future, the Company may experience cost increases on such purchases, and this can adversely impact profitability. China’s currency intervention strategy with respect to the U.S. Dollar continues to evolve. Future interventions by China may result in further currency appreciation and increase our product costs over time.

We identify foreign currency risk by regularly monitoring our foreign currency-denominated transactions and balances.  Where operating conditions permit, we reduce foreign currency risk by purchasing most of our inventory with U.S. Dollars and by converting cash balances denominated in foreign currencies to U.S. Dollars.

We have historically hedged against certain foreign currency exchange rate risk by using a series of forward contracts designated as cash flow hedges to protect against the foreign currency exchange risk inherent in our forecasted transactions denominated in currencies other than the U.S. Dollar.  In these transactions, we execute a forward currency contract that will settle at the end of a forecasted period.  Because the size and terms of the forward contract are designed so that its fair market value will move in the opposite direction and approximate magnitude of the underlying foreign currency’s forecasted exchange gain or loss during the forecasted period, a hedging relationship is created.  To the extent that we forecast the expected foreign currency cash flows from the period we enter into the forward contract until the date it will settle with reasonable accuracy, we significantly lower or materially eliminate a particular currency’s exchange rate risk exposure over the life of the related forward contract.  We enter into these types of agreements where we believe we have meaningful exposure to foreign currency exchange rate risk and the hedge pricing appears reasonable.  It is not practical for us to hedge all our exposures, nor are we able to project in any meaningful way, the possible effect and interplay of all foreign currency fluctuations on translated amounts or future earnings.  This is due to our constantly changing exposure to various currencies, the fact that each foreign currency reacts differently to the U.S. Dollar and the significant number of currencies involved. Accordingly, we will always be subject to foreign exchange rate risk on exposures we have not hedged, and these risks may be material.  We do not enter into any forward exchange contracts or similar instruments for trading or other speculative purposes.  We expect that as currency market conditions warrant, and our foreign denominated transaction exposure grows, we will continue to execute additional contracts in order to hedge against certain potential foreign exchange losses.

- 37 -

Interest Rate Risk:

Interest on our outstanding debt as of November 30, 2013 is both floating and fixed.  Fixed rates are in place on $100.00 million of Senior Notes at 3.90 percent, while floating rates are in place on $4.90 million of borrowings under our Credit Agreement, $35.51 million of interim draws under our MBFC Loan and $75.00 million of Senior Notes due June 2014.  If short-term interest rates increase, we will incur higher interest rates on any outstanding balances under the Credit Agreement and MBFC Loan. The floating rate Senior Notes due June 2014 reset as described in Note 9 in the accompanying consolidated condensed financial statements, and have been effectively converted to fixed rate debt using an interest rate swap (the “swap”), as described below.

We manage our floating rate $75.00 million of Senior Notes due June 2014 using an interest rate swap.  As of November 30, 2013, the swap converted an aggregate notional principal amount of $75.00 million from floating interest rate payments under our Senior Notes due June 2014 to fixed interest rate payments at 6.01 percent.  In the swap transaction, we maintain contracts to pay fixed rates of interest on an aggregate notional principal amount of $75.00 million at a rate of 5.11 percent on our Senior Notes due June 2014, while simultaneously receiving floating rate interest payments set at 0.25 percent as of November 30, 2013 on the same notional amounts.  The fixed rate side of the swap will not change over its life.  The floating rate payments are reset quarterly based on three month LIBOR.  The resets are concurrent with the interest payments made on the underlying debt. Changes in the spread between the fixed rate payment side of the swap and the floating rate receipt side of the swap offset 100 percent of the change in any period of the underlying debt’s floating rate payments.  The swap is used to reduce our risk of increased interest costs; however, when interest rates drop significantly below the swap rate, we lose the benefit that our floating rate debt would provide, if not managed with a swap. The swap is considered 100 percent effective.

The fair values of our various derivative instruments are as follows:

FAIR VALUES OF DERIVATIVE INSTRUMENTS

(in thousands)

November 30, 2013
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Non-current
Foreign currency contracts - sell Euro	Cash flow	6/2014	€	6,350	$	-	$	107	$	-
Foreign currency contracts - sell Pounds	Cash flow	8/2014	£	5,250	-		316		-
Interest rate swap	Cash flow	6/2014	$	75,000	-		2,136		-
Total fair value					$	-	$	2,559	$	-
February 28, 2013
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Non-current
Foreign currency contracts - sell Euro	Cash flow	10/2013	€	7,050	$	239	$	-	$	-
Foreign currency contracts - sell Pounds	Cash flow	11/2013	£	3,000	257		-		-
Interest rate swap	Cash flow	6/2014	$	75,000	-		3,044		1,780
Total fair value					$	496	$	3,044	$	1,780

Counterparty Credit Risk

Financial instruments, including foreign currency contracts and interest rate swaps, expose us to counterparty credit risk for nonperformance.  We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments.  Although our theoretical credit risk is the replacement cost at the then-estimated fair value of these instruments, we believe that the risk of incurring credit risk losses is remote.

- 38 -

INFORMATION REGARDING FORWARD-LOOKING STATEMENTS

Certain written and oral statements made by our Company and subsidiaries of our Company may constitute “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995. This includes statements made in this report, in other filings with the Securities and Exchange Commission (“SEC”), in press releases, and in certain other oral and written presentations. Generally, the words “anticipates”, “believes”, “expects”, “plans”, “may”, “will”, “should”, “seeks”, “estimates”, “project”, “predict”, “potential”, “continue”, “intends”, and other similar words identify forward-looking statements. All statements that address operating results, events or developments that we expect or anticipate will occur in the future, including statements related to sales, earnings per share results and statements expressing general expectations about future operating results, are forward-looking statements and are based upon our current expectations and various assumptions. We believe there is a reasonable basis for our expectations and assumptions, but there can be no assurance that we will realize our expectations or that our assumptions will prove correct. Forward-looking statements are subject to risks that could cause them to differ materially from actual results. Accordingly, we caution readers not to place undue reliance on forward-looking statements. We believe that these risks include, but are not limited to, the risks described in Part 1, Item 1A. “Risk Factors” of our annual report on Form 10-K for the year ended February 28, 2013 and risks otherwise described from time to time in our SEC reports as filed.  Such risks, uncertainties and other important factors include, among others:

·the departure and recruitment of key personnel;

·our ability to deliver products to our customers in a timely manner and according to their fulfillment standards;

·our geographic concentration of certain U.S. distribution facilities, which at certain times operate close to capacity, increases our exposure to significant shipping disruptions and added shipping and storage costs;

·difficulties encountered during the transition to our new distribution facility could interrupt our logistical systems and cause shipping disruptions;

·our projections of product demand, sales and net income are highly subjective in nature and future sales and net income could vary in a material amount from such projections;

·expectations regarding our recent and future acquisitions, including our ability to realize anticipated cost savings, synergies and other benefits along with our ability to effectively integrate acquired businesses;

·our relationship with key customers and licensors;

·the costs of complying with the business demands and requirements of large sophisticated customers;

·our dependence on foreign sources of supply and foreign manufacturing, and associated operational risks   including but not limited to long lead times, consistent local labor availability and capacity, and timely availability of sufficient shipping carrier capacity;

·the impact of changing costs of raw materials and energy on cost of goods sold and certain operating expenses;

·circumstances which may contribute to future impairment of goodwill, intangible or other long-lived assets;

·the risks associated with the use of trademarks licensed from and to third parties;

·our dependence on the strength of retail economies and vulnerabilities to a prolonged economic downturn;

·our ability to develop and introduce a continuing stream of new products to meet changing consumer preferences;

·disruptions in U.S., Euro zone and other international credit markets;

·foreign currency exchange rate fluctuations;

- 39 -

·trade barriers, exchange controls, expropriations, and other risks associated with foreign operations;

·the costs, complexity and challenges of upgrading and managing our global information systems;

·the risks associated with information security breaches;

·the risks associated with tax audits and related disputes with taxing authorities;

·the risks of potential changes in laws, including tax laws, health insurance laws and new regulations related to conflict minerals along with the costs and complexities of compliance with such laws; and

·our ability to continue to avoid classification as a controlled foreign corporation.

We undertake no obligation to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise.

- 40 -

ITEM 4. CONTROLS AND PROCEDURES

DISCLOSURE CONTROLS AND PROCEDURES

Our management, under the supervision and with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), maintains disclosure controls and procedures as defined in Rules 13a-15(e) under the Exchange Act that are designed to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosures. Because of inherent limitations, disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of disclosure controls and procedures are met.

Our management, including our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended November 30, 2013. Based upon that evaluation, the CEO and CFO concluded that our disclosure controls and procedures were effective at a reasonable level of assurance as of November 30, 2013, the end of the period covered by this quarterly report on Form 10-Q.

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

In connection with the evaluation described above, we identified no change in our internal control over financial reporting as defined in Rule 13a-15(f) of the Exchange Act that occurred during our fiscal quarter ended November 30, 2013, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

- 41 -

PART II.   OTHER INFORMATION

ITEM 1.   LEGAL PROCEEDINGS

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.

ITEM 1A.   RISK FACTORS

The ownership of our common stock involves a number of risks and uncertainties.  When evaluating the Company and our business before making an investment decision regarding our securities, potential investors should carefully consider the risk factors and uncertainties described in Part 1, Item 1A. “Risk Factors” of our annual report on Form 10-K for the fiscal year ended February 28, 2013.  Since the filing of our annual report on Form 10-K, there have been no material changes in our risk factors from those disclosed therein.

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

As of November 30, 2013, we were authorized by our Board of Directors to purchase up to 2,910,487 shares of common stock in the open market or through private transactions.  Unless extended by our Board of Directors, the existing repurchase program ends on October 31, 2014. Our current equity compensation plans include provisions that allow for the “net exercise” of stock options by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option holder can be paid for by having the option holder tender back to the Company a number of shares at fair value equal to the amounts due. Net exercises are accounted for by the Company as a purchase and retirement of shares.

During the fiscal quarter ended November 30, 2013, no shares of common stock were tendered by employees in “net exercise” transactions.  In addition, there were no open market common stock repurchases by the Company.  Accordingly, the following schedule shows no purchase activity for the three month period ended November 30, 2013:

ISSUER PURCHASES OF EQUITY SECURITIES FOR THE THREE MONTHS ENDED NOVEMBER 30, 2013

Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
September 1 through September 30, 2013	-	$	-	-	2,910,487
October 1 through October 31, 2013	-	-		-	2,910,487
November 1 through November 30, 2013	-	-		-	2,910,487
Total	-	$	-	-

- 42 -

ITEM 6.      EXHIBITS

(a)	Exhibits
	31.1*		Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
	31.2*		Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
	32**		Joint certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
	101.INS			XBRL Instance Document
	101.SCH			XBRL Taxonomy Extension Schema
	101.CAL			XBRL Taxonomy Extension Calculation Linkbase
	101.DEF			XBRL Taxonomy Extension Definition Linkbase
	101.LAB			XBRL Taxonomy Extension Label Linkbase
	101.PRE			XBRL Taxonomy Extension Presentation Linkbase
	*	Filed herewith.
	**	Furnished herewith.

- 43 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	HELEN OF TROY LIMITED
	(Registrant)
Date:   January 9, 2014	/s/ Gerald J. Rubin
	Gerald J. Rubin
	Chairman of the Board, Chief Executive Officer and President
Date:   January 9, 2014	/s/ Thomas J. Benson
	Thomas J. Benson
	Senior Vice President
	and Chief Financial Officer
Date:   January 9, 2014	/s/ Richard J. Oppenheim
	Richard J. Oppenheim
	Financial Controller
	(Principal Accounting Officer)

- 44 -

Index to Exhibits

31.1*	Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32**	Joint Certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema
101.CAL	XBRL Taxonomy Extension Calculation Linkbase
101.DEF	XBRL Taxonomy Extension Definition Linkbase
101.LAB	XBRL Taxonomy Extension Label Linkbase
101.PRE	XBRL Taxonomy Extension Presentation Linkbase

*	Filed herewith.
**	Furnished herewith.

- 45 -

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Gerald J. Rubin, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the fiscal quarter ended November 30, 2013 of Helen of Troy Limited;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:                January 9, 2014

/s/ Gerald J. Rubin

Gerald J. Rubin

Chairman of the Board, Chief Executive Officer and President

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Thomas J. Benson, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the fiscal quarter ended November 30, 2013 of Helen of Troy Limited;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:                      January 9, 2014

/s/ Thomas J. Benson

Thomas J. Benson

Senior Vice President and Chief Financial Officer

EX-32

EXHIBIT 32

CERTIFICATION

In connection with the quarterly report of Helen of Troy Limited (the “Company”) on Form 10-Q for the fiscal quarter ended November 30, 2013, as filed with the Securities and Exchange Commission (the “Report”), and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned, the Chairman of the Board, Chief Executive Officer and President and the Senior Vice President and Chief Financial Officer of the Company, hereby certifies that to the best of their knowledge:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:                  January 9, 2014

/s/ Gerald J. Rubin

Gerald J. Rubin

Chairman of the Board, Chief Executive Officer and President

/s/ Thomas J. Benson

Thomas J. Benson

Senior Vice President and Chief Financial Officer

This certification is not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. This certification is not deemed to be incorporated by reference into any filing under the Securities Act of 1933 or Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.

XML

Fair Value

9 Months Ended

Nov. 30, 2013

Fair Value

Fair Value

Note 11 – Fair Value

The fair value hierarchy of our financial assets and liabilities carried at fair value and measured on a recurring basis is as follows:

FAIR VALUES OF FINANCIAL ASSETS AND LIABILITIES

(in thousands)

			Quoted Prices in		Significant Other
			Active Markets		Observable
	Fair Values at		for Identical Assets		Market Inputs
Description	November 30, 2013		(Level 1)		(Level 2)
Assets:
Money market accounts	$	1,116	$	1,116	$	-
Total assets	$	1,116	$	1,116	$	-
Liabilities:
Long-term debt - fixed rate (1)	$	104,964	$	-	$	104,964
Long-term debt - floating rate	110,509		-		110,509
Interest rate swaps and foreign currency contracts	2,559		-		2,559
Total liabilities	$	218,032	$	-	$	218,032
			Quoted Prices in		Significant Other
			Active Markets		Observable
	Fair Values at		for Identical Assets		Market Inputs
Description	February 28, 2013		(Level 1)		(Level 2)
Assets:
Money market accounts	$	1,091	$	1,091	$	-
Foreign currency contracts	496		-		496
Total assets	$	1,587	$	1,091	$	496
Liabilities:
Long-term debt - fixed rate (1)	$	105,725	$	-	$	105,725
Long-term debt - floating rate	75,000		-		75,000
Interest rate swaps	4,824		-		4,824
Total liabilities	$	185,549	$	-	$	185,549

(1) Debt values are reported at estimated fair value in these tables, but are recorded in the accompanying consolidated condensed balance sheets at the undiscounted value of remaining principal payments due.

The carrying amounts of cash and cash equivalents, receivables and accounts payable approximate fair value because of the short maturity of these items.  Money market accounts are included in cash and cash equivalents in the accompanying consolidated condensed balance sheets and are classified as Level 1 assets.

We classify our fixed and floating rate debt as Level 2 liabilities because the estimation of the fair market value of these financial liabilities requires the use of discount rates based upon current market rates of interest for debt with comparable remaining terms. Such comparable rates are significant other observable market inputs. The fair market value of the fixed rate debt was computed using a discounted cash flow analysis and discount rates of 1.49 percent at November 30, 2013 and 1.83 percent February 28, 2013. All other long-term debt has floating interest rates, and its book value approximates its fair value as of the reporting date.

We use derivatives for hedging purposes and our derivatives are primarily foreign currency contracts and an interest rate swap. We determine the fair value of our derivative instruments based on Level 2 inputs in the fair value hierarchy. See Note 12 to these consolidated condensed financial statements for more information on our hedging activities.

The Company’s other non-financial assets include goodwill and other intangible assets, which we classify as Level 3 assets. These assets are measured at fair value on a non-recurring basis as part of the Company’s impairment assessments and as circumstances require. As discussed in Note 8, in connection with our annual impairment testing during the fiscal quarter ended May 31, 2013, we recorded a non-cash asset impairment charge of $12.05 million ($12.03 million after tax).  The charge related to certain trademarks in our Personal Care segment, which were written down to their estimated fair value, determined on the basis of future discounted cash flows using the relief from royalty valuation method.

XML

Consolidated Condensed Statements of Income (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Consolidated Condensed Statements of Income
Sales revenue, net	$ 380,730	$ 374,599	$ 1,004,633	$ 962,221
Cost of goods sold	233,029	226,146	613,513	575,590
Gross profit	147,701	148,453	391,120	386,631
Selling, general and administrative expense	98,308	101,401	278,697	277,590
Asset impairment charges			12,049
Operating income	49,393	47,052	100,374	109,041
Nonoperating income (expense), net	13	(16)	153	38
Interest expense	(2,513)	(3,232)	(7,647)	(9,674)
Income before income taxes	46,893	43,804	92,880	99,405
Income tax expense (benefit):
Current	10,911	11,705	24,780	26,093
Deferred	(1,542)	(5,620)	(7,133)	(10,847)
Net income	$ 37,524	$ 37,719	$ 75,233	$ 84,159
Earnings per share:
Basic (in dollars per share)	$ 1.17	$ 1.19	$ 2.35	$ 2.65
Diluted (in dollars per share)	$ 1.16	$ 1.18	$ 2.33	$ 2.64
Weighted average shares of common stock used in computing net earnings per share:
Basic (in shares)	32,047	31,775	31,982	31,739
Diluted (in shares)	32,482	31,970	32,311	31,885

XML

Earnings per Share

9 Months Ended

Nov. 30, 2013

Earnings per Share

Earnings per Share

Note 4 – Earnings per Share

We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period and diluted earnings per share using basic earnings per share plus the effect of dilutive securities. Our securities that can have dilutive effects consist of outstanding options to purchase common stock and issued and contingently issuable unvested restricted share units and awards.  See Note 14 to these consolidated condensed financial statements for more information regarding these restricted share units and awards. Options for common stock are excluded from the computation of diluted earnings per share if their effect is antidilutive.

For the periods covered in the accompanying consolidated condensed statements of income, the basic and diluted shares are as follows:

WEIGHTED AVERAGE DILUTED SECURITIES

(in thousands)

	Three Months Ended November 30,			Nine Months Ended November 30,
		2013	2012		2013	2012
Weighted average shares outstanding, basic		32,047	31,775		31,982	31,739
Incremental shares from share-based payment arrangements		435	195		329	146
Weighted average shares outstanding, diluted		32,482	31,970		32,311	31,885
Dilutive securities, as a result of in-the-money options		574	354		373	348
Dilutive securities, as a result of unvested restricted shares		408	143		298	143
Antidilutive securities, as a result of out-of-the-money options		358	612		586	618

XML

Comprehensive Loss (Tables)

9 Months Ended

Nov. 30, 2013

Comprehensive Loss

Schedule of components of accumulated other comprehensive loss

(in thousands)

	November 30,			February 28,
	2013			2013
Unrealized holding losses on cash flow hedges - interest rate swap, net of tax (1)	$	(1,388	)	$	(3,135	)
Unrealized holding gains (losses) on cash flow hedges - foreign currency contracts, net of tax (2)	(338		)	406
Total accumulated other comprehensive loss	$	(1,726	)	$	(2,729	)

(1)  Includes net deferred tax benefits of $0.75 and $1.69 million at November 30, 2013 and February 28, 2013, respectively.

(2)  Includes net deferred tax benefits (expense) of $0.09 and ($0.09) million at November 30, 2013 and February 28, 2013, respectively.

XML

Financial Instruments and Risk Management

9 Months Ended

Nov. 30, 2013

Financial Instruments and Risk Management

Financial Instruments and Risk Management

Note 12 – Financial Instruments and Risk Management

Foreign Currency Risk - Our functional currency is the U.S. Dollar. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”).  Such transactions include sales, certain inventory purchases and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies.  During the three- and nine-month periods ended November 30, 2013, approximately 16 and 15 percent, respectively, of our net sales revenue was in foreign currencies.  During the three- and nine-month periods ended November 30, 2012, approximately 18 and 17 percent, respectively, of our net sales revenue was in foreign currencies.  These sales were primarily denominated in British Pounds, Euros, Mexican Pesos, Canadian Dollars, Australian Dollars, Peruvian Soles, and Venezuelan Bolivares Fuertes. We make most of our inventory purchases from the Far East and use the U.S. Dollar for such purchases.  In our consolidated condensed statements of income, exchange gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets, and deferred tax liabilities, are recognized in their respective income tax lines, and all other foreign exchange gains and losses from remeasurement are recognized in SG&A.  For the three- and nine-month periods ended November 30, 2013, we recorded net foreign exchange gains (losses), including the impact of currency hedges, of $0.17 and ($0.33) million, respectively, in SG&A and ($0.19) and ($0.17) million, respectively, in income tax expense.  For the three- and nine-month periods ended November 30, 2012, we recorded net foreign exchange gains (losses), including the impact of currency hedges and currency swaps, of ($0.06) and ($0.23) million, respectively, in SG&A and ($0.07) and $0.10 million, respectively, in income tax expense.

We have historically hedged against certain foreign currency exchange rate risk by using a series of forward contracts designated as cash flow hedges to protect against the foreign currency exchange risk inherent in our forecasted transactions denominated in currencies other than the U.S. Dollar.  We do not enter into any forward exchange contracts or similar instruments for trading or other speculative purposes.

Interest Rate Risk – Interest on our outstanding debt as of November 30, 2013 is both floating and fixed.  Fixed rates are in place on $100.00 million of Senior Notes at 3.90 percent, while floating rates are in place on $4.90 million of borrowings under our Credit Agreement, $35.51 million of interim draws under our MBFC Loan and $75.00 million of Senior Notes due June 2014.  If short-term interest rates increase, we will incur higher interest rates on any outstanding balances under the Credit Agreement and MBFC Loan. The floating rate Senior Notes due June 2014 reset as described in Note 9, and have been effectively converted to fixed rate debt using an interest rate swap (the “swap”), as described below.

We manage our floating rate $75.00 million of Senior Notes due June 2014 using an interest rate swap.  As of November 30, 2013, the swap converted an aggregate notional principal amount of $75.00 million from floating interest rate payments under our Senior Notes due June 2014 to fixed interest rate payments at 6.01 percent.  In the swap transaction, we maintain contracts to pay fixed rates of interest on an aggregate notional principal amount of $75.00 million at a rate of 5.11 percent on our Senior Notes due June 2014, while simultaneously receiving floating rate interest payments set at 0.25 percent as of November 30, 2013 on the same notional amounts.  The fixed rate side of the swap will not change over its life.  The floating rate payments are reset quarterly based on three month LIBOR.  The resets are concurrent with the interest payments made on the underlying debt. Changes in the spread between the fixed rate payment side of the swap and the floating rate receipt side of the swap offset 100 percent of the change in any period of the underlying debt’s floating rate payments.  The swap is used to reduce our risk of increased interest costs; however, when interest rates drop significantly below the swap rate, we lose the benefit that our floating rate debt would provide, if not managed with a swap. The swap is considered 100 percent effective.

The fair values of our various derivative instruments are as follows:

FAIR VALUES OF DERIVATIVE INSTRUMENTS

(in thousands)

November 30, 2013
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Non-current
Foreign currency contracts - sell Euro	Cash flow	6/2014	€	6,350	$	-	$	107	$	-
Foreign currency contracts - sell Pounds	Cash flow	8/2014	£	5,250	-		316		-
Interest rate swap	Cash flow	6/2014	$	75,000	-		2,136		-
Total fair value					$	-	$	2,559	$	-

February 28, 2013
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Non-current
Foreign currency contracts - sell Euro	Cash flow	10/2013	€	7,050	$	239	$	-	$	-
Foreign currency contracts - sell Pounds	Cash flow	11/2013	£	3,000	257		-		-
Interest rate swap	Cash flow	6/2014	$	75,000	-		3,044		1,780
Total fair value					$	496	$	3,044	$	1,780

The pre-tax effect of derivative instruments for the periods covered in the accompanying consolidated condensed financial statements are as follows:

PRE-TAX EFFECT OF DERIVATIVE INSTRUMENTS

(in thousands)

	Three Months Ended November 30,
	Gain / (Loss)						Gain / (Loss) Reclassified
	Recognized in OCI						from Accumulated Other							Gain / (Loss) Recognized
	(effective portion)						Comprehensive Loss into Income							as Income (1)
	2013			2012			Location	2013			2012			Location	2013		2012
Currency contracts - cash flow hedges	$	(641	)	$	(596	)	SG&A	$	(78	)	$	(350	)	SG&A	$	-	$	(93	)
Interest rate swaps - cash flow hedges	(70		)	452			Interest expense	(946		)	(1,000		)		-		-
Total	$	(711	)	$	(144	)		$	(1,024	)	$	(1,350	)		$	-	$	(93	)

	Nine Months Ended November 30,
	Gain / (Loss)						Gain / (Loss) Reclassified
	Recognized in OCI						from Accumulated Other							Gain / (Loss) Recognized
	(effective portion)						Comprehensive Loss into Income							as Income (1)
	2013			2012			Location	2013			2012			Location	2013		2012
Currency contracts - cash flow hedges	$	(673	)	$	(619	)	SG&A	$	246		$	(313	)	SG&A	$	-	$	(44	)
Interest rate swaps - cash flow hedges	(97		)	(49		)	Interest expense	(2,785		)	(2,906		)		-		-
Total	$	(770	)	$	(668	)		$	(2,539	)	$	(3,219	)		$	-	$	(44	)

(1)  The amount shown represents the ineffective portion of the change in fair value of a cash flow hedge.

We expect net losses of $0.42 million associated with foreign currency contracts and $2.14 million associated with our interest rate swap, currently reported in accumulated other comprehensive loss, to be reclassified into income over the next nine months. The amount ultimately realized, however, will differ as exchange rates and interest rates change and the underlying contracts settle.

Counterparty Credit Risk- Financial instruments, including foreign currency contracts and interest rate swaps, expose us to counterparty credit risk for nonperformance.  We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments.  Although our theoretical credit risk is the replacement cost at the then-estimated fair value of these instruments, we believe that the risk of incurring credit risk losses is remote.

XML

Financial Instruments and Risk Management (Details 3) (Designated as cash flow hedging instruments) In Thousands, unless otherwise specified	Feb. 28, 2013 Prepaid Expenses and Other Current Assets USD ($)	Nov. 30, 2013 Accrued Expenses and Other Current Liabilities USD ($)	Feb. 28, 2013 Accrued Expenses and Other Current Liabilities USD ($)	Feb. 28, 2013 Other Liabilities, Non-current USD ($)	Nov. 30, 2013 Foreign currency contracts Euros EUR (€)	Feb. 28, 2013 Foreign currency contracts Euros EUR (€)	Feb. 28, 2013 Foreign currency contracts Euros Prepaid Expenses and Other Current Assets USD ($)	Nov. 30, 2013 Foreign currency contracts Euros Accrued Expenses and Other Current Liabilities USD ($)	Nov. 30, 2013 Foreign currency contracts Pounds GBP (£)	Feb. 28, 2013 Foreign currency contracts Pounds GBP (£)	Feb. 28, 2013 Foreign currency contracts Pounds Prepaid Expenses and Other Current Assets USD ($)	Nov. 30, 2013 Foreign currency contracts Pounds Accrued Expenses and Other Current Liabilities USD ($)	Nov. 30, 2013 Interest rate swaps USD ($)	Feb. 28, 2013 Interest rate swaps USD ($)	Nov. 30, 2013 Interest rate swaps Accrued Expenses and Other Current Liabilities USD ($)	Feb. 28, 2013 Interest rate swaps Accrued Expenses and Other Current Liabilities USD ($)	Feb. 28, 2013 Interest rate swaps Other Liabilities, Non-current USD ($)
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount, sell foreign currency					€ 6,350	€ 7,050			£ 5,250	£ 3,000
Notional Amount													75,000	75,000
Derivative assets	496						239				257
Derivative liabilities		$ 2,559	$ 3,044	$ 1,780				$ 107				$ 316			$ 2,136	$ 3,044	$ 1,780

XML

Supplemental Balance Sheet Information (Details 2) (USD $) In Thousands, unless otherwise specified	Nov. 30, 2013	Feb. 28, 2013
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued compensation, benefits and payroll taxes	$ 44,478	$ 34,265
Accrued sales returns, discounts and allowances	35,096	22,561
Accrued warranty returns	22,091	23,150
Accrued advertising	23,561	14,554
Accrued product liability, legal and professional fees	6,384	9,061
Accrued royalties	7,639	7,731
Accrued property, sales and other taxes	8,083	5,729
Derivative liabilities, current	2,559	3,044
Other	8,645	13,968
Total accrued expenses and other current liabilities	158,536	134,063
OTHER LIABILITIES, NON-CURRENT
Deferred compensation liability	7,908	6,443
Liability for uncertain tax positions	15,524	15,759
Derivative liabilities		1,780
Other liabilities	1,115	1,760
Total other liabilities, non-current	$ 24,547	$ 25,742

XML

Debt (Tables)

9 Months Ended

Nov. 30, 2013

Debt

Summary of long-term debt

(dollars in thousands)

	Original
	Date	Interest		November 30,			February 28,
	Borrowed	Rates	Matures	2013			2013
$38 million unsecured loan with a state industrial development corporation, interim draws, interest is set and payable quarterly at the Base Rate, as defined below, plus a margin of up to 1.125%, or applicable LIBOR plus a margin of up to 2.125%, as determined by the interest rate elected. Loan subject to holder’s call on or after March 1, 2018. Loan can be prepaid without penalty any
time after March 20, 2014.	03/13	1.17%	03/23	$	35,509		$	-
$75 million unsecured floating interest rate 10 year Senior Notes. Interest set and payable quarterly at three-month LIBOR plus 90 basis points. Principal is due in June 2014. Notes can be prepaid without penalty. (1)	06/04	6.01%	06/14	75,000			75,000
$100 million unsecured Senior Notes payable at a fixed interest rate of 3.90%. Interest payable semi-annually. Annual principal payments of $20 million begin in January 2014. Prepayment of notes are subject to a “make whole” premium.	01/11	3.90%	01/18	100,000			100,000
Total long-term debt				210,509			175,000
Less current maturities of long-term debt				(96,900		)	(20,000		)
Long-term debt, excluding current maturities				$	113,609		$	155,000

(1) Floating interest rates have been hedged with an interest rate swap to effectively fix interest rates. Additional information regarding the swap is provided in Note 12 to these consolidated condensed financial statements.

XML

Goodwill and Intangible Assets (Tables)

9 Months Ended

Nov. 30, 2013

Goodwill and Intangible Assets

Schedule of changes in goodwill and intangible assets by operating segment

(in thousands)

	November 30, 2013										February 28, 2013
	Gross		Cumulative								Gross		Cumulative
	Carrying		Goodwill			Accumulated			Net Book		Carrying		Goodwill			Accumulated			Net Book
Description	Amount		Impairments			Amortization			Value		Amount		Impairments			Amortization			Value
Housewares:
Goodwill	$	166,132	$	-		$	-		$	166,132	$	166,132	$	-		$	-		$	166,132
Trademarks - indefinite	75,200		-			-			75,200		75,200		-			-			75,200
Other intangibles - finite	15,794		-			(10,950		)	4,844		15,609		-			(10,070		)	5,539
Total Housewares	257,126		-			(10,950		)	246,176		256,941		-			(10,070		)	246,871
Healthcare / Home Environment:
Goodwill	251,758		-			-			251,758		251,758		-			-			251,758
Trademarks - indefinite	54,000		-			-			54,000		54,000		-			-			54,000
Licenses - finite	15,300		-			(5,676		)	9,624		15,300		-			(3,455		)	11,845
Other Intangibles - finite	114,490		-			(31,833		)	82,657		114,490		-			(23,220		)	91,270
Total Healthcare / Home Environment	435,548		-			(37,509		)	398,039		435,548		-			(26,675		)	408,873
Personal Care:
Goodwill	81,841		(46,490		)	-			35,351		81,841		(46,490		)	-			35,351
Trademarks - indefinite	63,754		-			-			63,754		75,803		-			-			75,803
Trademarks - finite	150		-			(76		)	74		150		-			(72		)	78
Licenses - indefinite	10,300		-			-			10,300		10,300		-			-			10,300
Licenses - finite	18,683		-			(15,807		)	2,876		18,683		-			(15,570		)	3,113
Other intangibles - finite	49,437		-			(25,162		)	24,275		49,437		-			(20,957		)	28,480
Total Personal Care	224,165		(46,490		)	(41,045		)	136,630		236,214		(46,490		)	(36,599		)	153,125
Total	$	916,839	$	(46,490	)	$	(89,504	)	$	780,845	$	928,703	$	(46,490	)	$	(73,344	)	$	808,869

Schedule of aggregate amortization expense of intangible assets

(in thousands)

For the three months ended
November 30, 2013	$	5,407
November 30, 2012	$	5,538

For the nine months ended
November 30, 2013	$	16,246
November 30, 2012	$	16,800

Schedule of estimated amortization expense of intangible assets

For the fiscal years ended
February 2014	$	21,556
February 2015	$	21,030
February 2016	$	20,847
February 2017	$	20,523
February 2018	$	16,703
February 2019	$	11,962

XML

Financial Instruments and Risk Management (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Foreign Currency Risk
Net foreign exchange gains (losses), including the impact of currency hedges and currency swaps, in SG&A	$ 0.17	$ (0.06)	$ (0.33)	$ (0.23)
Net foreign exchange gains (losses), including the impact of currency hedges and currency swaps, in income tax expense	$ (0.19)	$ (0.07)	$ (0.17)	$ 0.10
Net sales revenue | Geographic concentration | International operations - transactions denominated in foreign currencies
Foreign Currency Risk
Percentage of net sales revenue in foreign currencies	16.00%	18.00%	15.00%	17.00%

XML

Earnings per Share (Details)	3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Weighted average diluted securities
Weighted average shares outstanding, basic	32,047,000	31,775,000	31,982,000	31,739,000
Incremental shares from share-based payment arrangements	435,000	195,000	329,000	146,000
Weighted average shares outstanding, diluted	32,482,000	31,970,000	32,311,000	31,885,000
Antidilutive securities, as a result of out-of-the-money options (in shares)	358,000	612,000	586,000	618,000
Options
Dilutive securities, in-the-money and/or unvested
Dilutive securities (in shares)	574,000	354,000	373,000	348,000
Restricted Stock Awards
Dilutive securities, in-the-money and/or unvested
Dilutive securities (in shares)	408,000	143,000	298,000	143,000

XML

Debt (Details) (Credit Agreement, USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Revolving Line of Credit
Unsecured total revolving commitment	$ 250.00		$ 250.00
Number of alternative methods under which interest on borrowings accrue			2
Amount available for borrowings	244.82		244.82
Revolving loan
Revolving Line of Credit
Amount outstanding	4.90		4.90
Letter of credit
Revolving Line of Credit
Amount outstanding	$ 0.28		$ 0.28
Minimum
Revolving Line of Credit
Interest rate range during period (as a percent)	1.17%	1.59%	1.17%	1.59%
Maximum
Revolving Line of Credit
Interest rate range during period (as a percent)	3.25%	4.00%	3.63%	4.00%

XML

Financial Instruments and Risk Management (Details 4) (Cash flow hedges, USD $)	3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Pre-tax effect of derivative instruments
Gain/ (Loss) Recognized in OCI (effective portion)	$ (711,000)	$ (144,000)	$ (770,000)	$ (668,000)
Gain/ (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income	(1,024,000)	(1,350,000)	(2,539,000)	(3,219,000)
Gain/ (Loss) Recognized as Income		(93,000)		(44,000)
Foreign currency
Pre-tax effect of derivative instruments
Gain/ (Loss) Recognized in OCI (effective portion)	(641,000)	(596,000)	(673,000)	(619,000)
Gain/ (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income	(78,000)	(350,000)	246,000	(313,000)
Gain/ (Loss) Recognized as Income		(93,000)		(44,000)
Net losses currently reported in accumulated other comprehensive loss to be reclassified into income over the next ten months			420,000
Interest rate swaps
Pre-tax effect of derivative instruments
Gain/ (Loss) Recognized in OCI (effective portion)	(70,000)	452,000	(97,000)	(49,000)
Gain/ (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income	(946,000)	(1,000,000)	(2,785,000)	(2,906,000)
Net losses currently reported in accumulated other comprehensive loss to be reclassified into income over the next ten months			$ 2,140,000

XML

Share-Based Compensation Plans (Tables)

9 Months Ended

Nov. 30, 2013

Share-Based Compensation Plans

Schedule of share-based payment expense

(in thousands, except per share data)

	Three Months Ended November 30,				Nine Months Ended November 30,
	2013		2012		2013		2012
Stock options	$	589	$	572	$	1,791	$	1,731
Directors stock compensation	151		120		438		357
Performance-based restricted stock awards and units	1,708		701		6,944		2,296
Employee stock purchase plan	-		2		158		140
Share-based payment expense	2,448		1,395		9,331		4,524
Less income tax benefits	(466)		(203)		(1,877)		(661		)
Share-based payment expense, net of income tax benefits	$	1,982	$	1,192	$	7,454	$	3,863
Earnings per share impact of share-based payment expense:
Basic	$	0.06	$	0.04	$	0.23	$	0.12
Diluted	$	0.06	$	0.04	$	0.23	$	0.12

XML

Debt (Details 4) (USD $)	Nov. 30, 2013
Long-term debt
Limit on additional debt borrowings	$ 376,580,000
Fixed rate Senior Notes | Book value
Long-term debt
Fixed rate debt	100,000,000
Fixed rate Senior Notes | Fair Value, Level 2 | Discounted cash flow analysis
Long-term debt
Fixed rate debt	$ 104,960,000

XML

Supplemental Balance Sheet Information (Tables)

9 Months Ended

Nov. 30, 2013

Supplemental Balance Sheet Information

Schedule of property and equipment

(in thousands)

	Estimated
	Useful Lives	November 30,			February 28,
	(Years)	2013			2013
Land	-	$	12,800		$	12,800
Building and improvements	3 - 40	98,469			66,994
Computer, furniture and other equipment	3 - 15	60,002			58,284
Tools, molds and other production equipment	1 - 10	28,738			29,264
Construction in progress	-	5,144			9,149
Property and equipment, gross		205,153			176,491
Less accumulated depreciation		(74,576		)	(74,775		)
Property and equipment, net		$	130,577		$	101,716

Summary of accrued expenses and other current liabilities

(in thousands)

	November 30,		February 28,
	2013		2013
Accrued compensation, benefits and payroll taxes	$	44,478	$	34,265
Accrued sales returns, discounts and allowances	35,096		22,561
Accrued warranty returns	22,091		23,150
Accrued advertising	23,561		14,554
Accrued product liability, legal and professional fees	6,384		9,061
Accrued royalties	7,639		7,731
Accrued property, sales and other taxes	8,083		5,729
Derivative liabilities, current	2,559		3,044
Other	8,645		13,968
Total accrued expenses and other current liabilities	$	158,536	$	134,063

Summary of other non-current liabilities

(in thousands)

	November 30,		February 28,
	2013		2013
Deferred compensation liability	$	7,908	$	6,443
Liability for uncertain tax positions	15,524		15,759
Derivative liabilities	-		1,780
Other liabilites	1,115		1,760
Total other liabilities, non-current	$	24,547	$	25,742

XML

Consolidated Condensed Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Cash provided (used) by operating activities:
Net income	$ 75,233	$ 84,159
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	25,861	26,591
Provision for doubtful receivables	744	114
Non-cash share-based compensation	9,200	4,417
Intangible asset impairment charges	12,049
(Gain) loss on the sale of property and equipment	74	43
Deferred income taxes and tax credits	(7,136)	(10,906)
Changes in operating capital:
Receivables	(60,724)	(62,955)
Inventories	(9,018)	(60,052)
Prepaid expenses and other current assets	955	(512)
Other assets and liabilities, net	(1,340)	(469)
Accounts payable	21,478	16,414
Accrued expenses and other current liabilities	22,787	20,574
Accrued income taxes	949	6,909
Net cash provided by operating activities	91,112	24,327
Cash provided (used) by investing activities:
Capital and intangible asset expenditures	(38,563)	(6,405)
Proceeds from the sale or disposal of property and equipment		26
Note receivable from land sale		737
Net cash used by investing activities	(38,563)	(5,642)
Cash provided (used) by financing activities:
Proceeds from line of credit	107,300	184,950
Repayment of line of credit	(184,400)	(212,650)
Proceeds (repayments) of long-term debt	35,509	(3,000)
Payments of financing costs	(127)	(28)
Proceeds from share issuances under share-based compensation plans, including tax benefits	5,019	7,525
Payment of tax obligations resulting from issuance of restricted shares	(483)	(108)
Payments for repurchases of common stock	(1,311)	(1,759)
Share-based compensation tax benefit	1,877	661
Net cash used by financing activities	(36,616)	(24,409)
Net increase (decrease) in cash and cash equivalents	15,933	(5,724)
Cash and cash equivalents, beginning balance	12,842	21,846
Cash and cash equivalents, ending balance	$ 28,775	$ 16,122

XML

New Accounting Pronouncements

9 Months Ended

Nov. 30, 2013

New Accounting Pronouncements

New Accounting Pronouncements

Note 2 – New Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the FASB or other standards setting bodies that we adopt according to the various timetables the FASB specifies.  Unless otherwise discussed, we believe the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position, results of operations and cash flows upon adoption.

XML

Segment Information

9 Months Ended

Nov. 30, 2013

Segment Information

Segment Information

Note 5 – Segment Information

The following tables contain segment information for the periods covered in the accompanying consolidated condensed statements of income:

THREE MONTHS ENDED NOVEMBER 30, 2013 AND 2012

(in thousands)

			Healthcare /		Personal
November 30, 2013	Housewares		Home Environment		Care		Total
Sales revenue, net	$	74,776	$	165,752	$	140,202	$	380,730
Asset impairment charges	-		-		-		-
Operating income	15,278		10,665		23,450		49,393
Capital and intangible asset expenditures	193		3,207		585		3,985
Depreciation and amortization	897		5,349		2,726		8,972
			Healthcare /		Personal
November 30, 2012	Housewares		Home Environment		Care		Total
Sales revenue, net	$	67,787	$	158,174	$	148,638	$	374,599
Operating income	13,927		11,323		21,802		47,052
Capital and intangible asset expenditures	118		230		297		645
Depreciation and amortization	1,177		4,376		3,243		8,796
NINE MONTHS ENDED NOVEMBER 30, 2013 AND 2012
(in thousands)
			Healthcare /		Personal
November 30, 2013	Housewares		Home Environment		Care		Total
Sales revenue, net	$	208,471	$	424,398	$	371,764	$	1,004,633
Asset impairment charges	-		-		12,049		12,049
Operating income	41,506		22,175		36,693		100,374
Capital and intangible asset expenditures	574		36,321		1,668		38,563
Depreciation and amortization	2,946		14,897		8,018		25,861
			Healthcare /		Personal
November 30, 2012	Housewares		Home Environment		Care		Total
Sales revenue, net	$	192,606	$	391,061	$	378,554	$	962,221
Operating income	37,282		26,197		45,562		109,041
Capital and intangible asset expenditures	635		2,354		3,416		6,405
Depreciation and amortization	3,753		13,086		9,752		26,591

We compute operating income for each segment based on net sales revenue, less cost of goods sold, selling, general and administrative expense (“SG&A”), and any asset impairment charges associated with the segment. The SG&A used to compute each segment’s operating income is directly associated with the segment, plus overhead expenses that are allocable to the segment. We make allocations of overhead between operating segments using a number of relevant allocation criteria, depending on the nature of the expense, the most significant of which are relative revenues, estimates of relative labor expenditures, headcount, and facility square footage.  We do not allocate nonoperating income and expense, including interest or income taxes to operating segments.

XML

Commitments and Contingencies

9 Months Ended

Nov. 30, 2013

Commitments and Contingencies

Commitments and Contingencies

Note 3 – Commitments and Contingencies

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.

Notes 7, 9, 11, 12, and 14 provide additional information regarding certain of our significant commitments and certain significant contingencies we have provided for in the accompanying consolidated condensed financial statements.

Our products are under warranty against defects in material and workmanship for periods ranging from two to five years. We estimate our warranty accrual using historical trends and believe that these trends are the most reliable method by which we can estimate our warranty liability.  The following table summarizes the activity in our warranty accrual for the periods covered in the accompanying consolidated condensed statements of income:

ACCRUAL FOR WARRANTY RETURNS

(in thousands)

	Three Months Ended November 30,						Nine Months Ended November 30,
		2013			2012			2013			2012
Beginning balance		$	21,357		$	21,860		$	23,150		$	26,665
Additions to the accrual		6,504			11,027			25,280			25,800
Reductions of the accrual - payments and credits issued		(5,770		)	(7,496)			(26,339		)	(27,074		)
Ending balance		$	22,091		$	25,391		$	22,091		$	25,391

XML

Debt (Details 2) (USD $)	9 Months Ended
	Nov. 30, 2013	Feb. 28, 2013
Long-term debt
Total long-term debt	$ 210,509,000	$ 175,000,000
Less current maturities of long-term debt	(96,900,000)	(20,000,000)
Long-term debt, excluding current maturities	113,609,000	155,000,000
Unsecured state industrial development loan
Long-term debt
Face amount	38,000,000
Interest rate (as a percent)	1.17%
Total long-term debt	35,509,000
Unsecured floating interest rate 10 year Senior Notes
Long-term debt
Face amount	75,000,000
Interest rate (as a percent)	6.01%
Debt instrument term	10 years
Variable Rate Basis	three-month LIBOR
Basis spread on variable rate (as percent)	0.90%
Total long-term debt	75,000,000	75,000,000
3.90% unsecured Senior Notes payable
Long-term debt
Face amount	100,000,000
Interest rate (as a percent)	3.90%
Principal payments	20,000,000
Frequency of principal payment	Annual
Total long-term debt	$ 100,000,000	$ 100,000,000
Base Rate | Unsecured state industrial development loan
Long-term debt
Variable Rate Basis	Base rate
Base Rate | Unsecured state industrial development loan | Maximum
Long-term debt
Basis spread on variable rate (as percent)	1.125%
LIBOR | Unsecured state industrial development loan
Long-term debt
Variable Rate Basis	LIBOR
LIBOR | Unsecured state industrial development loan | Maximum
Long-term debt
Basis spread on variable rate (as percent)	2.125%

XML

Fair Value (Tables)

9 Months Ended

Nov. 30, 2013

Fair Value

Schedule of fair value hierarchy of financial assets and liabilities carried at fair value and measured on a recurring basis

(in thousands)

			Quoted Prices in		Significant Other
			Active Markets		Observable
	Fair Values at		for Identical Assets		Market Inputs
Description	November 30, 2013		(Level 1)		(Level 2)
Assets:
Money market accounts	$	1,116	$	1,116	$	-
Total assets	$	1,116	$	1,116	$	-
Liabilities:
Long-term debt - fixed rate (1)	$	104,964	$	-	$	104,964
Long-term debt - floating rate	110,509		-		110,509
Interest rate swaps and foreign currency contracts	2,559		-		2,559
Total liabilities	$	218,032	$	-	$	218,032
			Quoted Prices in		Significant Other
			Active Markets		Observable
	Fair Values at		for Identical Assets		Market Inputs
Description	February 28, 2013		(Level 1)		(Level 2)
Assets:
Money market accounts	$	1,091	$	1,091	$	-
Foreign currency contracts	496		-		496
Total assets	$	1,587	$	1,091	$	496
Liabilities:
Long-term debt - fixed rate (1)	$	105,725	$	-	$	105,725
Long-term debt - floating rate	75,000		-		75,000
Interest rate swaps	4,824		-		4,824
Total liabilities	$	185,549	$	-	$	185,549

(1) Debt values are reported at estimated fair value in these tables, but are recorded in the accompanying consolidated condensed balance sheets at the undiscounted value of remaining principal payments due.

XML

Basis of Presentation and Conventions Used in this Report (Details) (USD $)	9 Months Ended
	Nov. 30, 2013 item	Feb. 28, 2013
Basis of Presentation and Conventions Used in this Report
Common shares, par value (in dollars per share)	$ 0.10	$ 0.10
Number of segments	3

XML

Supplemental Balance Sheet Information (Details) (USD $) In Thousands, unless otherwise specified										9 Months Ended					9 Months Ended				9 Months Ended
	Nov. 30, 2013	Feb. 28, 2013	Nov. 30, 2013 Olive Branch, Mississippi distribution facility	Feb. 28, 2013 Olive Branch, Mississippi distribution facility	Nov. 30, 2013 Land	Feb. 28, 2013 Land	Nov. 30, 2013 Land Olive Branch, Mississippi distribution facility acre	Nov. 30, 2013 Building and improvements	Feb. 28, 2013 Building and improvements	Nov. 30, 2013 Building and improvements Minimum	Nov. 30, 2013 Building and improvements Maximum	Nov. 30, 2013 Building and improvements Olive Branch, Mississippi distribution facility sqft	Nov. 30, 2013 Computer, furniture and other equipment	Feb. 28, 2013 Computer, furniture and other equipment	Nov. 30, 2013 Computer, furniture and other equipment Minimum	Nov. 30, 2013 Computer, furniture and other equipment Maximum	Nov. 30, 2013 Tools, molds and other production equipment	Feb. 28, 2013 Tools, molds and other production equipment	Nov. 30, 2013 Tools, molds and other production equipment Minimum	Nov. 30, 2013 Tools, molds and other production equipment Maximum	Nov. 30, 2013 Construction in progress	Feb. 28, 2013 Construction in progress
PROPERTY AND EQUIPMENT
Estimated useful life										3 years	40 years				3 years	15 years			1 year	10 years
Property and equipment, gross	$ 205,153	$ 176,491	$ 35,220	$ 4,030	$ 12,800	$ 12,800		$ 98,469	$ 66,994				$ 60,002	$ 58,284			$ 28,738	$ 29,264			$ 5,144	$ 9,149
Less accumulated depreciation	(74,576)	(74,775)
Property and equipment, net	$ 130,577	$ 101,716
Area (in square feet or acres)							84					1,300,000

XML

Repurchase of Helen of Troy Common Stock (Details) (USD $) In Thousands, except Share data, unless otherwise specified		3 Months Ended	9 Months Ended		3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012 Open market transactions	Nov. 30, 2013 Open market transactions	Nov. 30, 2012 Open market transactions	May 31, 2013 Equity compensation plans Restricted stock awards and units Chief Executive Officer	Nov. 30, 2012 Equity compensation plans Stock options and Performance RSUs	Nov. 30, 2013 Equity compensation plans Stock options and Performance RSUs	Nov. 30, 2012 Equity compensation plans Stock options and Performance RSUs
Repurchase of Helen of Troy Common Stock
Shares authorized for purchase in the open market or through private transactions	2,910,487
Repurchase of common stock
Common stock repurchased and retired (in shares)		61,426	33,862	61,426	9,898	1,752	13,453	48,791
Common stock repurchased and retired, total purchase price or aggregate market value		$ 1,759	$ 1,311	$ 1,759	$ 350	$ 58	$ 490	$ 1,615
Average price per share (in dollars per share)		$ 28.64	$ 38.71	$ 28.64	$ 35.55	$ 33.18	$ 36.44	$ 33.11

XML

Fair Value (Details) (USD $)	3 Months Ended			9 Months Ended	12 Months Ended																												3 Months Ended
	May 31, 2012	May 31, 2013 Personal Care Trademarks - indefinite-lived	Nov. 30, 2013 Significant Other Observable Market Inputs (Level 2) Discounted cash flow analysis Long-term debt - fixed rate	Nov. 30, 2013 Significant Other Observable Market Inputs (Level 2) Discounted cash flow analysis Long-term debt - fixed rate One Senior Note	Feb. 28, 2013 Significant Other Observable Market Inputs (Level 2) Discounted cash flow analysis Long-term debt - fixed rate One Senior Note	Nov. 30, 2013 Fair value	Feb. 28, 2013 Fair value	Nov. 30, 2013 Fair value Long-term debt - fixed rate	Feb. 28, 2013 Fair value Long-term debt - fixed rate	Nov. 30, 2013 Fair value Long-term debt - floating rate	Feb. 28, 2013 Fair value Long-term debt - floating rate	Nov. 30, 2013 Fair value Significant Other Observable Market Inputs (Level 2)	Feb. 28, 2013 Fair value Significant Other Observable Market Inputs (Level 2)	Nov. 30, 2013 Fair value Significant Other Observable Market Inputs (Level 2) Long-term debt - fixed rate	Feb. 28, 2013 Fair value Significant Other Observable Market Inputs (Level 2) Long-term debt - fixed rate	Nov. 30, 2013 Fair value Significant Other Observable Market Inputs (Level 2) Long-term debt - floating rate	Feb. 28, 2013 Fair value Significant Other Observable Market Inputs (Level 2) Long-term debt - floating rate	Nov. 30, 2013 Recurring Fair Values	Feb. 28, 2013 Recurring Fair Values	Feb. 28, 2013 Recurring Fair Values Interest rate swaps	Feb. 28, 2013 Recurring Fair Values Foreign currency contracts	Nov. 30, 2013 Recurring Fair Values Interest rate swaps and foreign currency contracts	Nov. 30, 2013 Recurring Fair Values Money market accounts	Feb. 28, 2013 Recurring Fair Values Money market accounts	Nov. 30, 2013 Recurring Quoted Prices in Active Markets for Identical Assets (Level 1)	Feb. 28, 2013 Recurring Quoted Prices in Active Markets for Identical Assets (Level 1)	Nov. 30, 2013 Recurring Quoted Prices in Active Markets for Identical Assets (Level 1) Money market accounts	Feb. 28, 2013 Recurring Quoted Prices in Active Markets for Identical Assets (Level 1) Money market accounts	Feb. 28, 2013 Recurring Significant Other Observable Market Inputs (Level 2)	Feb. 28, 2013 Recurring Significant Other Observable Market Inputs (Level 2) Interest rate swaps	Feb. 28, 2013 Recurring Significant Other Observable Market Inputs (Level 2) Foreign currency contracts	Nov. 30, 2013 Recurring Significant Other Observable Market Inputs (Level 2) Interest rate swaps and foreign currency contracts	May 31, 2013 Non-recurring Personal Care Trademarks - indefinite-lived
Assets:
Cash and cash equivalents																							$ 1,116,000	$ 1,091,000			$ 1,116,000	$ 1,091,000
Derivative assets																					496,000										496,000
Total assets																		1,116,000	1,587,000						1,116,000	1,091,000			496,000
Liabilities:
Long-term debt			104,960,000					104,964,000	105,725,000	110,509,000	75,000,000			104,964,000	105,725,000	110,509,000	75,000,000
Derivative liabilities																				4,824,000		2,559,000								4,824,000		2,559,000
Total liabilities						218,032,000	185,549,000					218,032,000	185,549,000
Fair value additional disclosures
Discount rate (as a percent)				1.49%	1.83%
Non-cash impairment charges	0	12,049,000																															12,049,000
Non-cash impairment charges after tax		$ 12,030,000																															$ 12,030,000

XML

Consolidated Condensed Balance Sheets (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Nov. 30, 2013	Feb. 28, 2013
Consolidated Condensed Balance Sheets
Receivables - principally trade, allowances (in dollars)	$ 4,653	$ 5,031
Property and equipment, accumulated depreciation (in dollars)	74,576	74,775
Other intangible assets, accumulated amortization (in dollars)	89,504	73,344
Other assets, accumulated amortization (in dollars)	$ 6,214	$ 5,403
Cumulative preferred stock, non-voting, par (in dollars per share)	$ 1.00	$ 1.00
Cumulative preferred stock, non-voting, Authorized shares	2,000,000	2,000,000
Cumulative preferred stock, non-voting, issued shares	0	0
Common stock, par (in dollars per share)	$ 0.10	$ 0.10
Common stock, Authorized shares	50,000,000	50,000,000
Common stock, shares issued	32,053,272	31,868,416
Common stock, shares outstanding	32,053,272	31,868,416

XML

Goodwill and Intangible Assets

9 Months Ended

Nov. 30, 2013

Goodwill and Intangible Assets

Goodwill and Intangible Assets

Note 8 – Goodwill and Intangible Assets

Annual Impairment Testing in the First Quarter of Fiscal Year 2014 - We performed our annual evaluation of goodwill and indefinite-lived intangible assets for impairment during the first quarter of fiscal year 2014.  As a result of our testing of indefinite-lived trademarks and licenses, we recorded a non-cash asset impairment charge of $12.05 million ($12.03 million after tax).  The charge was related to certain trademarks in our Personal Care segment, which were written down to their estimated fair value, determined on the basis of future discounted cash flows using the relief from royalty valuation method.

Annual Impairment Testing in the First Quarter of Fiscal Year 2013 - We performed our annual evaluation of goodwill and indefinite-lived intangible assets for impairment during the first quarter of fiscal year 2013.   As a result, we concluded no asset impairment charges were required.  For fiscal year 2013, the estimated fair value of the indefinite-lived trademarks and licenses, reporting unit net assets and the Company’s estimated enterprise value exceeded their respective carrying values as of the date of the evaluation.

A summary of the carrying amounts and associated accumulated amortization for all intangible assets by operating segment follows:

GOODWILL AND INTANGIBLE ASSETS

(in thousands)

	November 30, 2013										February 28, 2013
	Gross		Cumulative								Gross		Cumulative
	Carrying		Goodwill			Accumulated			Net Book		Carrying		Goodwill			Accumulated			Net Book
Description	Amount		Impairments			Amortization			Value		Amount		Impairments			Amortization			Value
Housewares:
Goodwill	$	166,132	$	-		$	-		$	166,132	$	166,132	$	-		$	-		$	166,132
Trademarks - indefinite	75,200		-			-			75,200		75,200		-			-			75,200
Other intangibles - finite	15,794		-			(10,950		)	4,844		15,609		-			(10,070		)	5,539
Total Housewares	257,126		-			(10,950		)	246,176		256,941		-			(10,070		)	246,871
Healthcare / Home Environment:
Goodwill	251,758		-			-			251,758		251,758		-			-			251,758
Trademarks - indefinite	54,000		-			-			54,000		54,000		-			-			54,000
Licenses - finite	15,300		-			(5,676		)	9,624		15,300		-			(3,455		)	11,845
Other Intangibles - finite	114,490		-			(31,833		)	82,657		114,490		-			(23,220		)	91,270
Total Healthcare / Home Environment	435,548		-			(37,509		)	398,039		435,548		-			(26,675		)	408,873
Personal Care:
Goodwill	81,841		(46,490		)	-			35,351		81,841		(46,490		)	-			35,351
Trademarks - indefinite	63,754		-			-			63,754		75,803		-			-			75,803
Trademarks - finite	150		-			(76		)	74		150		-			(72		)	78
Licenses - indefinite	10,300		-			-			10,300		10,300		-			-			10,300
Licenses - finite	18,683		-			(15,807		)	2,876		18,683		-			(15,570		)	3,113
Other intangibles - finite	49,437		-			(25,162		)	24,275		49,437		-			(20,957		)	28,480
Total Personal Care	224,165		(46,490		)	(41,045		)	136,630		236,214		(46,490		)	(36,599		)	153,125
Total	$	916,839	$	(46,490	)	$	(89,504	)	$	780,845	$	928,703	$	(46,490	)	$	(73,344	)	$	808,869

The following table summarizes the amortization expense attributable to intangible assets for the periods covered in the accompanying consolidated condensed statements of income, as well as our estimated amortization expense for the fiscal years 2014 through 2019.

AMORTIZATION OF INTANGIBLE ASSETS

(in thousands)

Aggregate Amortization Expense
For the three months ended
November 30, 2013	$	5,407
November 30, 2012	$	5,538

Aggregate Amortization Expense
For the nine months ended
November 30, 2013	$	16,246
November 30, 2012	$	16,800

Estimated Amortization Expense
For the fiscal years ended
February 2014	$	21,556
February 2015	$	21,030
February 2016	$	20,847
February 2017	$	20,523
February 2018	$	16,703
February 2019	$	11,962

XML

Consolidated Condensed Statements of Comprehensive Income (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Income, Before Tax	$ 46,893	$ 43,804	$ 92,880	$ 99,405
Cash flow hedge activity, before tax
Total other comprehensive income, before tax	313	1,299	1,769	2,595
Comprehensive income, Before Tax	47,206	45,103	94,649	102,000
Income, Tax	(9,369)	(6,085)	(17,647)	(15,246)
Cash flow hedge activity, tax
Total other comprehensive income, tax	(196)	(514)	(766)	(968)
Comprehensive income, Tax	(9,565)	(6,599)	(18,413)	(16,214)
Net income	37,524	37,719	75,233	84,159
Cash flow hedge activity, net of tax
Total other comprehensive income, net of tax	117	785	1,003	1,627
Comprehensive income, net of tax	37,641	38,504	76,236	85,786
Interest rate swaps
Cash flow hedge activity, before tax
Changes in fair market value	(70)	452	(97)	(49)
Settlements reclassified to income	946	1,000	2,785	2,906
Subtotal	876	1,452	2,688	2,857
Cash flow hedge activity, tax
Changes in fair market value	24	(158)	34	17
Settlements reclassified to income	(330)	(350)	(975)	(1,017)
Subtotal	(306)	(508)	(941)	(1,000)
Cash flow hedge activity, net of tax
Changes in fair market value	(46)	294	(63)	(32)
Settlements reclassified to income	616	650	1,810	1,889
Subtotal	570	944	1,747	1,857
Foreign currency contracts:
Cash flow hedge activity, before tax
Changes in fair market value	(641)	(596)	(673)	(619)
Ineffectiveness recorded in income		93		44
Settlements reclassified to income	78	350	(246)	313
Subtotal	(563)	(153)	(919)	(262)
Cash flow hedge activity, tax
Changes in fair market value	125	64	136	73
Ineffectiveness recorded in income		(15)		2
Settlements reclassified to income	(15)	(55)	39	(43)
Subtotal	110	(6)	175	32
Cash flow hedge activity, net of tax
Changes in fair market value	(516)	(532)	(537)	(546)
Ineffectiveness recorded in income		78		46
Settlements reclassified to income	63	295	(207)	270
Subtotal	$ (453)	$ (159)	$ (744)	$ (230)

XML

Consolidated Condensed Balance Sheets (USD $) In Thousands, unless otherwise specified	Nov. 30, 2013	Feb. 28, 2013
Assets, current:
Cash and cash equivalents	$ 28,775	$ 12,842
Receivables - principally trade, less allowances of $4,653 and $5,031	279,699	219,719
Inventory, net	289,890	280,872
Prepaid expenses and other current assets	10,321	8,442
Income taxes receivable		1,800
Deferred tax assets, net	25,314	21,530
Total assets, current	633,999	545,205
Property and equipment, net of accumulated depreciation of $74,576 and $74,775	130,577	101,716
Goodwill	453,241	453,241
Other intangible assets, net of accumulated amortization of $89,504 and $73,344	327,604	355,628
Deferred tax assets, net	2,780	2,401
Other assets, net of accumulated amortization of $6,214 and $5,403	10,819	15,813
Total assets	1,559,020	1,474,004
Liabilities, current:
Revolving line of credit	4,900	82,000
Accounts payable, principally trade	93,322	72,263
Accrued expenses and other current liabilities	158,536	134,063
Income taxes payable	1,261
Deferred tax liabilities, net	243	339
Long-term debt, current maturities	96,900	20,000
Total liabilities, current	355,162	308,665
Long-term debt, excluding current maturities	113,609	155,000
Deferred tax liabilities, net	55,880	57,991
Other liabilities, non-current	24,547	25,742
Total liabilities	549,198	547,398
Commitments and contingencies
Stockholders' equity:
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued
Common stock, $0.10 par. Authorized 50,000,000 shares; 32,053,272 and 31,868,416 shares issued and outstanding	3,205	3,187
Additional paid in capital	172,766	164,471
Accumulated other comprehensive loss	(1,726)	(2,729)
Retained earnings	835,577	761,677
Total stockholders' equity	1,009,822	926,606
Total liabilities and stockholders' equity	$ 1,559,020	$ 1,474,004

XML

Share-Based Compensation Plans (Details) (USD $)	3 Months Ended		9 Months Ended		3 Months Ended	9 Months Ended		3 Months Ended		9 Months Ended				3 Months Ended	9 Months Ended	3 Months Ended		9 Months Ended		3 Months Ended	9 Months Ended	3 Months Ended	9 Months Ended	3 Months Ended	0 Months Ended				3 Months Ended		9 Months Ended
	Nov. 30, 2013 item	Nov. 30, 2012	Nov. 30, 2013 item	Nov. 30, 2012	Nov. 30, 2012 Employee stock purchase plan	Nov. 30, 2013 Employee stock purchase plan	Nov. 30, 2012 Employee stock purchase plan	Nov. 30, 2013 Stock options	Nov. 30, 2012 Stock options	Nov. 30, 2013 Stock options	Nov. 30, 2012 Stock options	Nov. 30, 2013 Stock options Minimum	Nov. 30, 2013 Stock options Maximum	Nov. 30, 2013 Stock option exercises	Nov. 30, 2013 Stock option exercises	Nov. 30, 2013 Restricted Stock Award Board members	Nov. 30, 2012 Restricted Stock Award Board members	Nov. 30, 2013 Restricted Stock Award Board members	Nov. 30, 2012 Restricted Stock Award Board members	Nov. 30, 2013 Restricted Stock Award Board members Minimum	Nov. 30, 2013 Restricted Stock Award Board members Minimum	Nov. 30, 2013 Restricted Stock Award Board members Maximum	Nov. 30, 2013 Restricted Stock Award Board members Maximum	May 31, 2013 Restricted Stock Award Time-based vesting Chief Executive Officer and President	Mar. 02, 2012 RSUs Performance-based Chief Executive Officer and President	Mar. 02, 2012 RSUs Vesting on April 22, 2013 Chief Executive Officer and President	Mar. 02, 2012 RSUs Vesting on February 28, 2014 Chief Executive Officer and President	Mar. 02, 2012 RSUs Vesting on February 28, 2015 Chief Executive Officer and President	Nov. 30, 2013 Restricted stock awards and units Performance-based	Nov. 30, 2012 Restricted stock awards and units Performance-based	Nov. 30, 2013 Restricted stock awards and units Performance-based	Nov. 30, 2012 Restricted stock awards and units Performance-based
Share-Based Compensation Plans
Number of expired share-based compensation plans	2		2
Number of active share-based compensation plans	3		3
Share-based compensation plans
Granted in period (in shares)								4,000		262,750
Exercise prices of grants (in dollars per share)												$ 36.03	$ 46.38
Estimated grant date fair value (in dollars per share)												$ 10.82	$ 13.39
Term of award												4 years	5 years
Expected life												4 years 18 days	4 years 4 months 6 days
Range of risk-free interest rates used, minimum (as a percent)										0.55%
Range of risk-free interest rates used, maximum (as a percent)										1.14%
Expected dividend rate (as a percent)										0.00%
Range of expected volatility rates used, minimum (as a percent)										34.87%
Range of expected volatility rates used, maximum (as a percent)										41.67%
Restricted stock disclosure
Grant Date Fair Value, Total																$ 150,000		$ 440,000
Fair values at the date of grant of awards granted (in dollars per share)																				$ 36.56	$ 36.56	$ 40.23	$ 40.23	$ 35.55	$ 32.88
Number of awards granted (in shares)																								159,666	100,000	33,400	33,300	33,300
Number of awards granted, net of settlement (in shares)																2,628		7,884
Cash paid in settlement of grant			483,000	108,000												50,000		130,000
Fair values at the date of grant of awards granted																								5,680,000	3,290,000
Stock options exercised (in shares)														17,139	170,859
Shares of common stock purchased by employees						20,028
SHARE-BASED PAYMENT EXPENSE
Share-based payment expense	2,448,000	1,395,000	9,331,000	4,524,000	2,000	158,000	140,000	589,000	572,000	1,791,000	1,731,000					151,000	120,000	438,000	357,000										1,708,000	701,000	6,944,000	2,296,000
Less income tax benefits	(466,000)	(203,000)	(1,877,000)	(661,000)
Share-based payment expense, net of income tax benefits	$ 1,982,000	$ 1,192,000	$ 7,454,000	$ 3,863,000
Earnings per share impact of share-based payment expense:
Basic (in dollars per share)	$ 0.06	$ 0.04	$ 0.23	$ 0.12
Diluted (in dollars per share)	$ 0.06	$ 0.04	$ 0.23	$ 0.12

XML

Financial Instruments and Risk Management (Tables)

9 Months Ended

Nov. 30, 2013

Financial Instruments and Risk Management

Schedule of fair values of derivative instruments

(in thousands)

November 30, 2013
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Non-current
Foreign currency contracts - sell Euro	Cash flow	6/2014	€	6,350	$	-	$	107	$	-
Foreign currency contracts - sell Pounds	Cash flow	8/2014	£	5,250	-		316		-
Interest rate swap	Cash flow	6/2014	$	75,000	-		2,136		-
Total fair value					$	-	$	2,559	$	-

February 28, 2013
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Non-current
Foreign currency contracts - sell Euro	Cash flow	10/2013	€	7,050	$	239	$	-	$	-
Foreign currency contracts - sell Pounds	Cash flow	11/2013	£	3,000	257		-		-
Interest rate swap	Cash flow	6/2014	$	75,000	-		3,044		1,780
Total fair value					$	496	$	3,044	$	1,780

Schedule of pre-tax effect of derivative instruments

(in thousands)

	Three Months Ended November 30,
	Gain / (Loss)						Gain / (Loss) Reclassified
	Recognized in OCI						from Accumulated Other							Gain / (Loss) Recognized
	(effective portion)						Comprehensive Loss into Income							as Income (1)
	2013			2012			Location	2013			2012			Location	2013		2012
Currency contracts - cash flow hedges	$	(641	)	$	(596	)	SG&A	$	(78	)	$	(350	)	SG&A	$	-	$	(93	)
Interest rate swaps - cash flow hedges	(70		)	452			Interest expense	(946		)	(1,000		)		-		-
Total	$	(711	)	$	(144	)		$	(1,024	)	$	(1,350	)		$	-	$	(93	)

	Nine Months Ended November 30,
	Gain / (Loss)						Gain / (Loss) Reclassified
	Recognized in OCI						from Accumulated Other							Gain / (Loss) Recognized
	(effective portion)						Comprehensive Loss into Income							as Income (1)
	2013			2012			Location	2013			2012			Location	2013		2012
Currency contracts - cash flow hedges	$	(673	)	$	(619	)	SG&A	$	246		$	(313	)	SG&A	$	-	$	(44	)
Interest rate swaps - cash flow hedges	(97		)	(49		)	Interest expense	(2,785		)	(2,906		)		-		-
Total	$	(770	)	$	(668	)		$	(2,539	)	$	(3,219	)		$	-	$	(44	)

(1)  The amount shown represents the ineffective portion of the change in fair value of a cash flow hedge.

XML

Segment Information (Tables)

9 Months Ended

Nov. 30, 2013

Segment Information

Schedule of segment information

THREE MONTHS ENDED NOVEMBER 30, 2013 AND 2012

(in thousands)

			Healthcare /		Personal
November 30, 2013	Housewares		Home Environment		Care		Total
Sales revenue, net	$	74,776	$	165,752	$	140,202	$	380,730
Asset impairment charges	-		-		-		-
Operating income	15,278		10,665		23,450		49,393
Capital and intangible asset expenditures	193		3,207		585		3,985
Depreciation and amortization	897		5,349		2,726		8,972
			Healthcare /		Personal
November 30, 2012	Housewares		Home Environment		Care		Total
Sales revenue, net	$	67,787	$	158,174	$	148,638	$	374,599
Operating income	13,927		11,323		21,802		47,052
Capital and intangible asset expenditures	118		230		297		645
Depreciation and amortization	1,177		4,376		3,243		8,796
NINE MONTHS ENDED NOVEMBER 30, 2013 AND 2012
(in thousands)
			Healthcare /		Personal
November 30, 2013	Housewares		Home Environment		Care		Total
Sales revenue, net	$	208,471	$	424,398	$	371,764	$	1,004,633
Asset impairment charges	-		-		12,049		12,049
Operating income	41,506		22,175		36,693		100,374
Capital and intangible asset expenditures	574		36,321		1,668		38,563
Depreciation and amortization	2,946		14,897		8,018		25,861
			Healthcare /		Personal
November 30, 2012	Housewares		Home Environment		Care		Total
Sales revenue, net	$	192,606	$	391,061	$	378,554	$	962,221
Operating income	37,282		26,197		45,562		109,041
Capital and intangible asset expenditures	635		2,354		3,416		6,405
Depreciation and amortization	3,753		13,086		9,752		26,591

XML

Income Taxes (Details) (USD $)	3 Months Ended			9 Months Ended
	Nov. 30, 2013	May 31, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Income Taxes
Effective income tax rate (as a percent)	20.00%		13.90%	19.00%	15.30%
Asset impairment charges		$ 12,049,000		$ 12,049,000
Tax benefit related to asset impairment charges		$ 20,000

XML

Goodwill and Intangible Assets (Details) (USD $)	3 Months Ended			9 Months Ended																									3 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	May 31, 2012	Nov. 30, 2013	Nov. 30, 2012	Feb. 28, 2013	Nov. 30, 2013 Housewares	Feb. 28, 2013 Housewares	Nov. 30, 2013 Housewares Other Intangibles - finite-lived	Feb. 28, 2013 Housewares Other Intangibles - finite-lived	Nov. 30, 2013 Housewares Trademarks - indefinite-lived	Feb. 28, 2013 Housewares Trademarks - indefinite-lived	Nov. 30, 2013 Healthcare/Home Environment	Feb. 28, 2013 Healthcare/Home Environment	Nov. 30, 2013 Healthcare/Home Environment Licenses - finite-lived	Feb. 28, 2013 Healthcare/Home Environment Licenses - finite-lived	Nov. 30, 2013 Healthcare/Home Environment Other Intangibles - finite-lived	Feb. 28, 2013 Healthcare/Home Environment Other Intangibles - finite-lived	Nov. 30, 2013 Healthcare/Home Environment Trademarks - indefinite-lived	Feb. 28, 2013 Healthcare/Home Environment Trademarks - indefinite-lived	Nov. 30, 2013 Personal Care	Feb. 28, 2013 Personal Care	Nov. 30, 2013 Personal Care Trademarks - finite-lived	Feb. 28, 2013 Personal Care Trademarks - finite-lived	Nov. 30, 2013 Personal Care Licenses - finite-lived	Feb. 28, 2013 Personal Care Licenses - finite-lived	Nov. 30, 2013 Personal Care Other Intangibles - finite-lived	Feb. 28, 2013 Personal Care Other Intangibles - finite-lived	May 31, 2013 Personal Care Trademarks - indefinite-lived	Nov. 30, 2013 Personal Care Trademarks - indefinite-lived	Feb. 28, 2013 Personal Care Trademarks - indefinite-lived	Nov. 30, 2013 Personal Care Licenses - indefinite-lived	Feb. 28, 2013 Personal Care Licenses - indefinite-lived
Goodwill and intangible assets
Goodwill impairment charges			$ 0
Non-cash indefinite-lived intangible assets impairment charges			0																										12,049,000
Non-cash indefinite-lived intangible assets impairment charges, net of tax																													12,030,000
Changes in Goodwill
Goodwill Gross Carrying Amount							166,132,000	166,132,000					251,758,000	251,758,000							81,841,000	81,841,000
Cumulative Goodwill Impairments	(46,490,000)			(46,490,000)		(46,490,000)															(46,490,000)	(46,490,000)
Goodwill Net Book Value	453,241,000			453,241,000		453,241,000	166,132,000	166,132,000					251,758,000	251,758,000							35,351,000	35,351,000
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, Gross Carrying Amount											75,200,000	75,200,000							54,000,000	54,000,000										63,754,000	75,803,000	10,300,000	10,300,000
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, Gross Carrying Amount									15,794,000	15,609,000					15,300,000	15,300,000	114,490,000	114,490,000					150,000	150,000	18,683,000	18,683,000	49,437,000	49,437,000
Intangible assets - finite-lived, Accumulated Amortization	(89,504,000)			(89,504,000)		(73,344,000)	(10,950,000)	(10,070,000)	(10,950,000)	(10,070,000)			(37,509,000)	(26,675,000)	(5,676,000)	(3,455,000)	(31,833,000)	(23,220,000)			(41,045,000)	(36,599,000)	(76,000)	(72,000)	(15,807,000)	(15,570,000)	(25,162,000)	(20,957,000)
Intangible assets - finite-lived, Net Book Value									4,844,000	5,539,000					9,624,000	11,845,000	82,657,000	91,270,000					74,000	78,000	2,876,000	3,113,000	24,275,000	28,480,000
Goodwill and intangible assets
Gross Carrying Amount	916,839,000			916,839,000		928,703,000	257,126,000	256,941,000					435,548,000	435,548,000							224,165,000	236,214,000
Net Book Value	780,845,000			780,845,000		808,869,000	246,176,000	246,871,000					398,039,000	408,873,000							136,630,000	153,125,000
Aggregate Amortization Expense	5,407,000	5,538,000		16,246,000	16,800,000
Estimated Amortization Expense
February 2014	21,556,000			21,556,000
February 2015	21,030,000			21,030,000
February 2016	20,847,000			20,847,000
February 2017	20,523,000			20,523,000
February 2018	16,703,000			16,703,000
February 2019	$ 11,962,000			$ 11,962,000

XML

Segment Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended			9 Months Ended
	Nov. 30, 2013	May 31, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Segment information
Sales revenue, net	$ 380,730		$ 374,599	$ 1,004,633	$ 962,221
Asset impairment charges		12,049		12,049
Operating income	49,393		47,052	100,374	109,041
Capital and intangible asset expenditures	3,985		645	38,563	6,405
Depreciation and amortization	8,972		8,796	25,861	26,591
Housewares
Segment information
Sales revenue, net	74,776		67,787	208,471	192,606
Operating income	15,278		13,927	41,506	37,282
Capital and intangible asset expenditures	193		118	574	635
Depreciation and amortization	897		1,177	2,946	3,753
Healthcare/Home Environment
Segment information
Sales revenue, net	165,752		158,174	424,398	391,061
Operating income	10,665		11,323	22,175	26,197
Capital and intangible asset expenditures	3,207		230	36,321	2,354
Depreciation and amortization	5,349		4,376	14,897	13,086
Personal Care
Segment information
Sales revenue, net	140,202		148,638	371,764	378,554
Asset impairment charges				12,049
Operating income	23,450		21,802	36,693	45,562
Capital and intangible asset expenditures	585		297	1,668	3,416
Depreciation and amortization	$ 2,726		$ 3,243	$ 8,018	$ 9,752

XML

Comprehensive Loss (Details) (USD $)	Nov. 30, 2013	Feb. 28, 2013
Unrealized holding gains (losses) on cash flow hedges	$ (1,726,000)	$ (2,729,000)
Interest rate swaps
Unrealized holding gains (losses) on cash flow hedges	(1,388,000)	(3,135,000)
Net deferred tax benefits	750,000	1,690,000
Foreign currency contracts
Unrealized holding gains (losses) on cash flow hedges	(338,000)	406,000
Net deferred tax benefits	90,000
Net deferred tax expense		$ 90,000

XML

Supplemental Balance Sheet Information

9 Months Ended

Nov. 30, 2013

Supplemental Balance Sheet Information

Supplemental Balance Sheet Information

Note 7 – Supplemental Balance Sheet Information

PROPERTY AND EQUIPMENT

(in thousands)

	Estimated
	Useful Lives	November 30,			February 28,
	(Years)	2013			2013
Land	-	$	12,800		$	12,800
Building and improvements	3 - 40	98,469			66,994
Computer, furniture and other equipment	3 - 15	60,002			58,284
Tools, molds and other production equipment	1 - 10	28,738			29,264
Construction in progress	-	5,144			9,149
Property and equipment, gross		205,153			176,491
Less accumulated depreciation		(74,576		)	(74,775		)
Property and equipment, net		$	130,577		$	101,716

Property and equipment includes cumulative capital expenditures of $35.22 and $4.03 million as of November 30, 2013 and February 28, 2013, respectively, in connection with our new 1.3 million square foot distribution facility on approximately 84 acres of land in Olive Branch, Mississippi.  The new facility will consolidate the operations of our U.S. based Personal Care and Healthcare / Home Environment appliance businesses.  The new facility became operational for the Healthcare / Home Environment segment during the first week of September 2013.  We expect to complete the transition of our domestic Personal Care appliance distribution to the new facility in the first quarter of fiscal year 2015.  Remaining capital expenditure commitments in connection with the Personal Care appliance move are not expected to be material.  See Note 9 to these consolidated condensed financial statements for related information regarding the debt incurred to fund the construction of the new distribution facility.

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

(in thousands)

	November 30,		February 28,
	2013		2013
Accrued compensation, benefits and payroll taxes	$	44,478	$	34,265
Accrued sales returns, discounts and allowances	35,096		22,561
Accrued warranty returns	22,091		23,150
Accrued advertising	23,561		14,554
Accrued product liability, legal and professional fees	6,384		9,061
Accrued royalties	7,639		7,731
Accrued property, sales and other taxes	8,083		5,729
Derivative liabilities, current	2,559		3,044
Other	8,645		13,968
Total accrued expenses and other current liabilities	$	158,536	$	134,063

OTHER LIABILITIES, NON-CURRENT

(in thousands)

	November 30,		February 28,
	2013		2013
Deferred compensation liability	$	7,908	$	6,443
Liability for uncertain tax positions	15,524		15,759
Derivative liabilities	-		1,780
Other liabilites	1,115		1,760
Total other liabilities, non-current	$	24,547	$	25,742

XML

Repurchase of Helen of Troy Common Stock (Tables)

9 Months Ended

Nov. 30, 2013

Repurchase of Helen of Troy Common Stock

Schedule of repurchase of common stock

	Three Months Ended November 30,				Nine Months Ended November 30,
	2013		2012		2013		2012
Common stock repurchased on the open market
Number of shares	-		61,426		33,862		61,426
Aggregate market value of shares (in thousands)	$	-	$	1,759	$	1,311	$	1,759
Average price per share	$	-	$	28.64	$	38.71	$	28.64
Common stock received in settlement of stock options and Performance RSUs
Number of shares	-		1,752		13,453		48,791
Aggregate market value of shares (in thousands)	$	-	$	58	$	490	$	1,615
Average price per share	$	-	$	33.18	$	36.44	$	33.11

XML

Debt (Details 3) (USD $) In Millions, unless otherwise specified		9 Months Ended				0 Months Ended
	Nov. 30, 2013 Unsecured state industrial development loan	Nov. 30, 2013 Unsecured state industrial development loan LIBOR	Nov. 30, 2013 Unsecured state industrial development loan Maximum LIBOR	Mar. 02, 2013 MBFC Maximum	Mar. 02, 2013 Kaz USA Unsecured state industrial development loan	Mar. 02, 2013 Kaz USA Unsecured state industrial development loan After March 1, 2018	Mar. 02, 2013 Kaz USA Unsecured state industrial development loan Base Rate Loan Base rate	Mar. 02, 2013 Kaz USA Unsecured state industrial development loan Base Rate Loan LIBOR	Mar. 02, 2013 Kaz USA Unsecured state industrial development loan Base Rate Loan Federal Funds Rate	Mar. 02, 2013 Kaz USA Unsecured state industrial development loan Base Rate Loan Bank of America's prime rate	Mar. 02, 2013 Kaz USA Unsecured state industrial development loan Eurodollar Rate Loans LIBOR	Mar. 02, 2013 Kaz USA Unsecured state industrial development loan Minimum Base Rate Loan Base rate	Mar. 02, 2013 Kaz USA Unsecured state industrial development loan Minimum Eurodollar Rate Loans LIBOR	Mar. 02, 2013 Kaz USA Unsecured state industrial development loan Maximum Base Rate Loan Base rate	Mar. 02, 2013 Kaz USA Unsecured state industrial development loan Maximum Eurodollar Rate Loans LIBOR
Long-term debt
Taxable industrial development revenue bonds				$ 38.00
Face amount	38
Interim draws, maximum					38.00
Variable Rate Basis		LIBOR					Base rate	one-, two-, three-, or six-month LIBOR	federal funds	prime rate of Bank of America	one-, two-, three-, or six-month LIBOR
Margin (as a percent)			2.125%					1.00%	0.50%			0.00%	1.00%	1.125%	2.125%
Outstanding principal payable on March 1, 2014					1.90
Outstanding principal payable on March 1, 2015					1.90
Outstanding principal payable on March 1, 2016					3.80
Outstanding principal payable on March 1, 2017					5.70
Outstanding principal payable on March 1, 2018					1.90
Outstanding principal payable on March 1, 2019					1.90
Outstanding principal payable on March 1, 2020					1.90
Outstanding principal payable on March 1, 2021					1.90
Outstanding principal payable on March 1, 2022					1.90
Outstanding principal payable on March 1, 2023					$ 15.20
Notice period for prepayment of debt by Bank of America, N.A.						90 days

XML

Income Taxes

9 Months Ended

Nov. 30, 2013

Income Taxes

Income Taxes

Note 10 – Income Taxes

Income tax expense for the three- and nine-month periods ended November 30, 2013 was 20.0 and 19.0 percent of income before income taxes, respectively, compared to 13.9 and 15.3 percent, respectively, for the same periods last year.  The year-over-year comparison of our effective tax rate for the quarter was impacted by discrete items that were a benefit to tax expense in the third quarter of the prior fiscal year, and shifts in the mix of taxable income between our various tax jurisdictions. Our effective tax rate for the nine months ended November 30, 2013 was also impacted by asset impairment charges of $12.05 million recorded in the first quarter of fiscal year 2014, for which the related tax benefit was only $0.02 million.

XML

Comprehensive Loss

9 Months Ended

Nov. 30, 2013

Comprehensive Loss

Comprehensive Loss

Note 6 – Comprehensive Loss

The components of accumulated other comprehensive loss, net of tax, are as follows:

COMPONENTS OF ACCUMULATED OTHER COMPREHENSIVE LOSS

(in thousands)

	November 30,			February 28,
	2013			2013
Unrealized holding losses on cash flow hedges - interest rate swap, net of tax (1)	$	(1,388	)	$	(3,135	)
Unrealized holding gains (losses) on cash flow hedges - foreign currency contracts, net of tax (2)	(338		)	406
Total accumulated other comprehensive loss	$	(1,726	)	$	(2,729	)

(1)  Includes net deferred tax benefits of $0.75 and $1.69 million at November 30, 2013 and February 28, 2013, respectively.

(2)  Includes net deferred tax benefits (expense) of $0.09 and ($0.09) million at November 30, 2013 and February 28, 2013, respectively.

XML

Basis of Presentation and Conventions Used in this Report

9 Months Ended

Nov. 30, 2013

Basis of Presentation and Conventions Used in this Report

Basis of Presentation and Conventions Used in this Report

Note 1 - Basis of Presentation and Conventions Used in this Report

The accompanying consolidated condensed financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly our consolidated financial position as of November 30, 2013 and February 28, 2013, and the results of our consolidated operations for the three- and nine-month periods ended November 30, 2013 and 2012. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2013, and our other reports on file with the Securities and Exchange Commission (“SEC”).

In this report and the accompanying consolidated condensed financial statements and notes, unless the context suggests otherwise or otherwise indicated, references to “the Company”, “our Company”, “Helen of Troy”,  “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries, and amounts are expressed in thousands of U.S. Dollars.  We refer to the Company’s common shares, par value $0.10 per share, as “common stock.” References to “Kaz” refer to the operations of Kaz, Inc. and its subsidiaries.  References to “PUR” refer to the PUR brand of water filtration products that we acquired, along with certain other assets and liabilities, from The Procter & Gamble Company and certain of its affiliates. Kaz and PUR comprise a segment within the Company referred to as the Healthcare / Home Environment segment.  References to “OXO” refer to the operations of OXO International and certain of its affiliated subsidiaries that comprise our Housewares segment.  Product and service names mentioned in this report are used for identification purposes only and may be protected by trademarks, trade names, services marks, and/or other intellectual property rights of the Company and/or other parties in the United States and/or other jurisdictions. The absence of a specific attribution in connection with any such mark does not constitute a waiver of any such right. All trademarks, trade names, service marks, and logos referenced herein belong to their owners.  References to “the FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to U.S. generally accepted accounting principles. References to “ASC” refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB.

We are a global designer, developer, importer, marketer, and distributor of an expanding portfolio of brand-name consumer products.  We have three segments: Housewares, Healthcare / Home Environment and Personal Care.  Our Housewares segment provides a broad range of innovative consumer products for the home. Product offerings include food preparation and storage, cleaning, organization, and baby and toddler care products. The Healthcare / Home Environment segment focuses on health care devices such as thermometers, blood pressure monitors, humidifiers, and heating pads; water filtration systems; and small home appliances such as air purifiers, portable heaters, fans, and insect control devices (bug zappers).  Our Personal Care segment’s products include electric hair care, beauty care and wellness appliances; grooming tools and accessories; and liquid, solid- and powder-based personal care and grooming products. All three segments sell their products primarily through mass merchandisers, drugstore chains, warehouse clubs, catalogs, grocery stores, and specialty stores.  In addition, the Healthcare / Home Environment segment sells certain of its product lines through medical distributors and other products through home improvement stores, and the Personal Care segment sells extensively through beauty supply retailers and wholesalers. Our business is seasonal due to different calendar events, holidays, and seasonal weather patterns. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30th. We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico and the United States.

Our consolidated condensed financial statements are prepared in accordance with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates.  We have reclassified, combined or separately disclosed certain amounts in the prior period’s consolidated condensed financial statements and accompanying footnotes to conform to the current period’s presentation.

XML

Financial Instruments and Risk Management (Details 2) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Nov. 30, 2013
Credit Agreement
Financial instruments and risk management
Borrowings	$ 4.90
Fixed rate Senior Notes
Financial instruments and risk management
Fixed rate debt	100.00
Fixed interest rate (as a percent)	3.90%
Floating interest rate Senior Notes due June 2014
Financial instruments and risk management
Senior Notes Bearing Variable Interest Amount	75.00
Unsecured state industrial development loan
Financial instruments and risk management
Debt instrument intermediate draws	35.51
Effective fixed interest rate on debt (as a percent)	1.17%
Interest rate swaps | Floating interest rate Senior Notes due June 2014
Financial instruments and risk management
Aggregate notional principal amount	$ 75.00
Effective fixed interest rate on debt (as a percent)	6.01%
Derivative fixed interest rate (as a percent)	5.11%
Derivative variable rate (as a percent)	0.25%
Base rate, description	three-month LIBOR
Percentage of change in floating interest rate offset by swap	100.00%
Effectiveness percentage of swap	100.00%

XML

Commitments and Contingencies (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Accrual for warranty returns
Beginning balance	$ 21,357	$ 21,860	$ 23,150	$ 26,665
Additions to the accrual	6,504	11,027	25,280	25,800
Reductions of the accrual - payments and credits issued	(5,770)	(7,496)	(26,339)	(27,074)
Ending balance	$ 22,091	$ 25,391	$ 22,091	$ 25,391
Minimum
Warranties
Product warranty period			2 years
Maximum
Warranties
Product warranty period			5 years

XML

Repurchase of Helen of Troy Common Stock

9 Months Ended

Nov. 30, 2013

Repurchase of Helen of Troy Common Stock

Repurchase of Helen of Troy Common Stock

Note 13 – Repurchase of Helen of Troy Common Stock

As of November 30, 2013, we were authorized by our Board of Directors to purchase up to 2,910,487 shares of common stock in the open market or through private transactions.  Our current equity compensation plans include provisions that allow for the “net exercise” of stock options by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option holder can be paid for by having the option holder tender back to the Company a number of shares at fair value equal to the amounts due. Net exercises are accounted for by the Company as a purchase and retirement of shares.

During the fiscal quarter ended May 31, 2013, our Chief Executive Officer and President (the “CEO”) tendered 9,898 shares of restricted common stock having a market value of $0.35 million as payment for related federal tax obligations arising from the vesting and settlement of performance-based restricted share units (“Performance RSUs”). We accounted for this activity as a purchase and retirement of the shares at a price of $35.55 per share.

For the periods covered in the accompanying consolidated condensed financial statements, open market repurchase activity and common stock option exercises resulted in the following share repurchases:

SHARE REPURCHASES
	Three Months Ended November 30,				Nine Months Ended November 30,
	2013		2012		2013		2012
Common stock repurchased on the open market
Number of shares	-		61,426		33,862		61,426
Aggregate market value of shares (in thousands)	$	-	$	1,759	$	1,311	$	1,759
Average price per share	$	-	$	28.64	$	38.71	$	28.64
Common stock received in settlement of stock options and Performance RSUs
Number of shares	-		1,752		13,453		48,791
Aggregate market value of shares (in thousands)	$	-	$	58	$	490	$	1,615
Average price per share	$	-	$	33.18	$	36.44	$	33.11

XML

Debt

9 Months Ended

Nov. 30, 2013

Debt

Debt

Note 9 – Debt

Revolving Line of Credit - We have a Credit Agreement (the “Credit Agreement”) with Bank of America, N.A. that provides for an unsecured total revolving commitment of up to $250.00 million. The commitment under the Credit Agreement terminates on December 30, 2015.  Borrowings accrue interest under one of two alternative methods as described in the Credit Agreement.  With each borrowing against our credit line, we can elect the interest rate method based on our funding needs at the time.  We also incur loan commitment fees and letter of credit fees under the Credit Agreement.  Outstanding letters of credit reduce the borrowing availability under the Credit Agreement on a dollar-for-dollar basis.  As of November 30, 2013, the outstanding revolving loan principal balance was $4.90 million and there were $0.28 million of open letters of credit outstanding against the Credit Agreement. For the three- and nine-months ended November 30, 2013, borrowings under the Credit Agreement incurred interest charges at rates ranging from 1.17 to 3.25 percent and 1.17 to 3.63 percent, respectively.  For both the three- and nine-months ended November 30, 2012, borrowings under the Credit Agreement incurred interest charges at rates ranging from 1.59 to 4.00 percent.  As of November 30, 2013, the amount available for borrowings under the Credit Agreement was $244.82 million.

Long-Term Debt – A summary of our long-term debt is as follows:

LONG-TERM DEBT

(dollars in thousands)

	Original
	Date	Interest		November 30,			February 28,
	Borrowed	Rates	Matures	2013			2013
$38 million unsecured loan with a state industrial development corporation, interim draws, interest is set and payable quarterly at the Base Rate, as defined below, plus a margin of up to 1.125%, or applicable LIBOR plus a margin of up to 2.125%, as determined by the interest rate elected. Loan subject to holder’s call on or after March 1, 2018. Loan can be prepaid without penalty any
time after March 20, 2014.	03/13	1.17%	03/23	$	35,509		$	-
$75 million unsecured floating interest rate 10 year Senior Notes. Interest set and payable quarterly at three-month LIBOR plus 90 basis points. Principal is due in June 2014. Notes can be prepaid without penalty. (1)	06/04	6.01%	06/14	75,000			75,000
$100 million unsecured Senior Notes payable at a fixed interest rate of 3.90%. Interest payable semi-annually. Annual principal payments of $20 million begin in January 2014. Prepayment of notes are subject to a “make whole” premium.	01/11	3.90%	01/18	100,000			100,000
Total long-term debt				210,509			175,000
Less current maturities of long-term debt				(96,900		)	(20,000		)
Long-term debt, excluding current maturities				$	113,609		$	155,000

(1) Floating interest rates have been hedged with an interest rate swap to effectively fix interest rates. Additional information regarding the swap is provided in Note 12 to these consolidated condensed financial statements.

In March 2013, Kaz USA, Inc. (“Kaz USA”), a wholly owned subsidiary of the Company, entered into a Loan Agreement, dated as of March 1, 2013, with the Mississippi Business Finance Corporation (the “MBFC”) in connection with the issuance by the MBFC of up to $38.00 million of taxable industrial development revenue bonds (the “Bonds”). The Bonds are issued under a Trust Indenture (the “IRB Indenture”), between the MBFC and Deutsche Bank National Trust Company, as trustee.  Interim draws, accumulating up to a $38.00 million aggregate maximum, may be made through March 20, 2014.  The Bonds and the related loan to Kaz USA (the “MBFC Loan”) will bear interest at a variable rate as elected by Kaz USA equal to either (a) a “Base Rate” plus a margin of 0.00 to 1.125 percent, depending upon the leverage ratio at the time of the borrowing or (b) the respective one-, two-, three-, or six-month LIBOR rate plus 1.00 to 2.125 percent, depending upon the leverage ratio at the time of the borrowing.  The Base Rate is equal to the highest of  (i) the federal funds rate for the day, plus 0.50 percent, (ii) the prime rate of Bank of America, N.A., or (iii) the respective one-, two-, three-, or six-month LIBOR rate plus 1.00 percent.  The proceeds of the MBFC Loan have been used by Kaz USA to finance the purchase of land, construction of a distribution facility and the acquisition and installation of equipment, machinery and related assets located in Olive Branch, Mississippi.

Assuming the $38.00 million aggregate maximum is borrowed, outstanding principal of the MBFC Loan will be payable as follows: $1.90 million on March 1 in each of 2014, 2015, 2018, 2019, 2020, 2021 and 2022; $3.80 million on March 1, 2016; $5.70 million on March 1, 2017; and $15.20 million on March 1, 2023. Any remaining outstanding principal and interest is due upon maturity on March 1, 2023.  The MBFC Loan may be prepaid in whole or part without penalty any time after March 20, 2014.  Additionally, Bank of America, N.A., the purchaser of the Bonds, may elect for the MBFC Loan to be prepaid in full on March 1, 2018.  Following March 1, 2018, Bank of America, N.A. may elect for the MBFC Loan to be prepaid on March 1 of each subsequent year prior to maturity upon at least 90 days notice. In lieu of any prepayment, the Bonds may be purchased by a transferee, as permitted under the IRB Indenture.

The fair market value of the fixed rate debt at November 30, 2013, computed using a discounted cash flow analysis, was $104.96 million compared to the $100.00 million book value and represents a Level 2 liability. All other long-term debt has floating interest rates, and its book value approximates its fair value at November 30, 2013.

All of our debt is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries. Our debt agreements require the maintenance of certain financial covenants, including maximum leverage ratios, minimum interest coverage ratios and minimum consolidated net worth levels (as each of these terms is defined in the various agreements).  Our debt agreements also contain other customary covenants, including, among other things, covenants restricting or limiting the Company, except under certain conditions set forth therein, from (1) incurring debt, (2) incurring liens on its properties, (3) making certain types of investments, (4) selling certain assets or making other fundamental changes relating to mergers and consolidations, and (5) repurchasing shares of our common stock and paying dividends.

As of November 30, 2013, our debt agreements effectively limited our ability to incur more than $376.58 million of additional debt from all sources, including draws on the Credit Agreement. As of November 30, 2013, we were in compliance with the terms of all of our debt agreements.

XML

Earnings per Share (Tables)

9 Months Ended

Nov. 30, 2013

Earnings per Share

Schedule of components of basic and diluted shares

(in thousands)

	Three Months Ended November 30,			Nine Months Ended November 30,
		2013	2012		2013	2012
Weighted average shares outstanding, basic		32,047	31,775		31,982	31,739
Incremental shares from share-based payment arrangements		435	195		329	146
Weighted average shares outstanding, diluted		32,482	31,970		32,311	31,885
Dilutive securities, as a result of in-the-money options		574	354		373	348
Dilutive securities, as a result of unvested restricted shares		408	143		298	143
Antidilutive securities, as a result of out-of-the-money options		358	612		586	618

XML

Share-Based Compensation Plans

9 Months Ended

Nov. 30, 2013

Share-Based Compensation Plans

Share-Based Compensation Plans

Note 14 – Share-Based Compensation Plans

We have share-based awards outstanding under two expired and three active share-based compensation plans.

During the three- and nine-months ended November 30, 2013, the Company granted options to purchase 4,000 and 262,750 shares of common stock, respectively, to certain of our officers, employees and new hires.  For the fiscal year-to-date, these options were granted at exercise prices ranging from $36.03 to $46.38 per share.  The fair values of the options were estimated using the Black-Scholes option pricing model to estimate fair values ranging from $10.82 to $13.39 for grants with terms of four and five years.  The following assumptions were used for the grants: expected lives ranging from 4.05 to 4.35 years; risk-free interest rates ranging from 0.55 to 1.14 percent; zero dividend yield; and expected volatilities ranging from 34.87 to 41.67 percent.

During the three- and nine-month periods ending November 30, 2013, the Company awarded restricted stock grants with total values of $0.15  and $0.44  million, respectively, to certain Board members based upon fair values at the date of grant ranging from $36.56 to $40.23, respectively.  Over the same three- and nine-month periods, the grants were settled with 2,628 and 7,884 restricted shares, respectively, and cash of $0.05 and $0.13 million, respectively.  The restricted stock awards vested immediately.

In the first quarter of fiscal year 2014, under the terms of his employment agreement, bonus plan and relevant stock plans, our CEO earned and received the following equity awards as a component of his fiscal year 2013 performance-based incentive compensation:

· 159,666 shares of restricted stock with a total grant date fair value of $5.68 million, or $35.55 per share, which vest on February 28, 2015; and

· 100,000 Performance RSUs, originally granted on March 1, 2012 with an original grant date fair market value of $3.29 million, or $32.88 per share, of which 33,400 shares vested on April 22, 2013, 33,300 shares vest on February 28, 2014 and 33,300 shares vest on February 28, 2015.

We are recording the expense for these awards in accordance with their vesting over their related service periods.

Accruals for the CEO’s remaining Performance RSUs and the CEO’s restricted stock awards associated with his annual bonus are subject to the achievement of specified performance goals for the fiscal year and are estimated until earned, subject to a probability assessment of achieving the associated performance criteria.  These accruals and the service period expense associated with the CEO’s fiscal year 2013 and 2014 awards are shown in the line below entitled “Performance-based restricted stock awards and units.”

During the three- and nine-months ended November 30, 2013, employees and directors exercised stock options to purchase 17,139 and 170,859 shares of common stock, respectively.  During the nine months ended November 30, 2013, employees purchased 20,028 shares of common stock through our Employee Stock Purchase Plan.

We recorded share-based compensation expense in SG&A for the periods covered in the accompanying consolidated condensed financial statements as follows:

SHARE-BASED PAYMENT EXPENSE

(in thousands, except per share data)

	Three Months Ended November 30,				Nine Months Ended November 30,
	2013		2012		2013		2012
Stock options	$	589	$	572	$	1,791	$	1,731
Directors stock compensation	151		120		438		357
Performance-based restricted stock awards and units	1,708		701		6,944		2,296
Employee stock purchase plan	-		2		158		140
Share-based payment expense	2,448		1,395		9,331		4,524
Less income tax benefits	(466)		(203)		(1,877)		(661		)
Share-based payment expense, net of income tax benefits	$	1,982	$	1,192	$	7,454	$	3,863
Earnings per share impact of share-based payment expense:
Basic	$	0.06	$	0.04	$	0.23	$	0.12
Diluted	$	0.06	$	0.04	$	0.23	$	0.12

XML

Document and Entity Information	9 Months Ended
	Nov. 30, 2013	Jan. 03, 2014
Document and Entity Information
Entity Registrant Name	HELEN OF TROY LTD
Entity Central Index Key	0000916789
Document Type	10-Q
Document Period End Date	Nov. 30, 2013
Amendment Flag	false
Current Fiscal Year End Date	--02-28
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		32,064,062
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3

XML

Commitments and Contingencies (Tables)

9 Months Ended

Nov. 30, 2013

Commitments and Contingencies

Schedule of accrual for warranty returns

(in thousands)

	Three Months Ended November 30,						Nine Months Ended November 30,
		2013			2012			2013			2012
Beginning balance		$	21,357		$	21,860		$	23,150		$	26,665
Additions to the accrual		6,504			11,027			25,280			25,800
Reductions of the accrual - payments and credits issued		(5,770		)	(7,496)			(26,339		)	(27,074		)
Ending balance		$	22,091		$	25,391		$	22,091		$	25,391